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Crystallization is an important separation and purification technique for a wide variety 
of solid products in pharmaceutical, food and fine chemical industries. The production of 
more than 90% of the active pharmaceutical ingredients (APIs) involves crystallization. 
Therefore, it is crucial to design and control pharmaceutical crystallization processes so 
that the desired process requirement and product critical quality attributes (CQAs), 
including process yield, crystal purity, crystal size distribution (CSD), crystal shape and 
polymorphic form can be obtained. Studies about cooling or antisolvent only batch 
crystallization of pure APIs have been extensively reported in the literature in the last 
century. But design and control of more complex and integrated crystallization operation 
and systems require further development to meet the needs of improved CQAs, simplified 
process design and automated process control in pharmaceutical manufacturing. 
This dissertation focuses on the development of novel design and control approaches 
for three different types of integrated crystallization operation and systems: (1) combined 
cooling/antisolvent crystallization (CCAC) systems; (2) integrated crystallization and wet 
milling operation; (3) crystallization systems in the presence of impurities. The design and 
xxix 
 
control of both batch and, more recently, continuous crystallization systems were studied 
using population balance model (PBM), process analytical technology (PAT) and feedback 
control strategies. 
First, CCAC systems in both batch and continuous mixed suspension mixed product 
removal (MSMPR) cascade crystallizer configurations were designed and controlled via 
model-based approaches. PBM-based optimization techniques were used. A linear 
operating profile based fast design strategy was developed to achieve desired crystal size 
and yield for batch CCAC systems, which was experimentally validated. The steady-state 
operation of continuous MSMPR cascade crystallizers was optimized and compared with 
batch operation. An efficient startup procedure was modeled and demonstrated able to 
provide large improvement on startup duration and waste minimization. In addition, two 
control frameworks, decentralized proportional-integral-derivative (PID) control and 
nonlinear model predictive control (NMPC), were investigated in two stage MSMPR 
cascade crystallizers, with both yield and crystal size targeted as controlled variables, 
providing a systematic strategy to compute attainable regions of particle size under 
different control configurations. 
The second part of this dissertation is dedicated to design and control integrated 
crystallization and wet milling operation. A toothed rotor-stator lab scale wet mill unit was 
integrated with continuous mixed suspension mixed product removal crystallizer 
(MSMPRC). It was used upstream as a continuous nucleator for in situ seed generation, 
and used downstream as a continuous size reduction unit through recycling. The 
experimental results indicate that the integrated crystallization and wet milling operation 
can lead to improved yield, CSD and process startup compared to crystallization operation 
xxx 
 
without wet milling. A PAT-based feedback control approach called automated direct 
nucleation control (ADNC), was developed to achieve consistent and automated closed-
loop control on CSD in continuous MSMPR cascade crystallizers. This ADNC approach 
was also extended to integrated continuous crystallization and wet milling operation, and 
a wet milling-based automated direct nucleation control (WMADNC) approach was 
developed to achieve improved control of CSD. 
In the last part of this dissertation, an ultra-performance liquid chromatography (UPLC) 
system with automated process sampling and dilution was developed as an online PAT tool 
for the first time to monitor crystallization systems in the presence of impurities. Three 
online UPLC-based applications were proposed and implemented, including concentration 
monitoring in crystallization and degradation, quick calibration for UV/vis and Raman 
spectroscopy, and real-time crystallization product purity monitoring. 
In this dissertation, a series of novel applications were proposed and validated via 
simulation and/or experimental studies that demonstrated the significance of quality-by-
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CHAPTER 1. INTRODUCTION 
1.1 Background 
Crystallization is a very efficient and economical separation and purification technique, 
in which a solute can transfer from liquid solution to a pure crystalline phase. It is one of 
the oldest unit operations used in chemical, food and pharmaceutical industries (Mullin, 
2001). More than 90% of the active pharmaceutical ingredients (APIs) are crystals of small 
organic molecules and would require at least one crystallization step in their manufacture 
(Alvarez et al., 2010; Wong, et al., 2012). In pharmaceutical industry, crystallization is 
widely used to purify the APIs produced from organic synthesis or fermentation and then 
followed by filtration, drying, milling, granulation, tableting, etc. Due to the safety concern 
of impurities and strict regulatory requirements, purity is always one of the most important 
critical quality attributes (CQAs) in pharmaceutical crystallization process. In general, very 
high purity (e.g. > 99.9%) is required in the crystallization of APIs. Besides, the crystal 
polymorphic form is another important CQA, since different polymorphs of a same API 
can have significantly different solubility, dissolution behavior and bioavailability in 
human body. In addition, crystallization is not only a separation technique, but also an 
important particle technology. The crystal size distribution (CSD) and crystal shape 
significantly influence the efficiency of downstream operations such as filtration and 




Typically, large and uniform crystals that have small aspect ratio are desired considering 
manufacturability. But in some situations small and uniform crystals are also of great 
importance due to their improved bioavailability compared to large crystals. Considering 
the requirements of various CQAs as well as the process yield, the design and control of 
crystallization process is important and challenging in pharmaceutical industry. 
There are various ways to carry out crystallization, such as through cooling, antisolvent 
addition, or evaporation. Cooling and antisolvent addition are the two common ways used 
in pharmaceutical crystallization because of the purification purpose. The design and 
control of cooling only or antisolvent only crystallization processes to achieve desired 
CQAs have been extensively reported in literature since last century (Aamir et al., 2010; 
Hermanto et al., 2010; Ma and Wang, 2012; Nagy et al., 2013; Nowee et al., 2008). 
However, in pharmaceutical industry, in many situations a combined cooling/antisolvent 
crystallization (CCAC) method is actually used in order to maximize the process yield. 
Due to the extra freedom in process parameters, the integrated CCAC system, which has 
not yet been widely studied in literature, is more challenging to design and control but also 
more promising to further improve the desired CQAs in both batch and continuous 
processes (Nagy et al., 2008b). 
In addition, crystallization is typically investigated in literature on its own as a single 
unit operation. As a result, the ability to control CQAs, such as size and shape, is very 
limited. The integration of other unit operations into crystallization process is of great 
interests in recent years. For example, wet milling is a widely used unit operation to tailor 
the particle size distribution (PSD) of slurry. It is typically used in downstream to improve 




found that by integrating wet milling with batch crystallization, one could not only reduce 
the number of unit operations and intensify the process, but also achieve better control on 
crystal quality (Engstrom et al., 2013; Kougoulos et al., 2011). Therefore, integrated 
crystallization and wet milling operation, especially for integrated continuous 
crystallization, is a very novel and promising direction in industrial crystallization. 
What is more, impurity is a crucial aspect in crystallization process development. 
Generally speaking, crystallization of multi-component system (e.g. API with impurities) 
is much more challenging to study than single component system (e.g. pure API). There 
are several reasons. First of all, pure API of a certain polymorph in a particular solvent 
always has a fixed solubility curve which is not difficult to measure or search for in 
literature, whereas the API solubility could be different when impurity is present (Simone 
et al., 2015c). In addition, the nucleation and growth kinetics of the components in solution 
could be influenced by each other (Abbou Oucherif et al., 2013). Lastly, the compositions 
of solid and liquid phases of a multicomponent system are difficult to characterize in real-
time. For instance, spectroscopy techniques are useful to measure concentration of single 
component system however often not useful when impurity is present due to the overlapped 
spectra. Because of the above reasons, although large amount of crystallization papers are 
available in literature, most of them use pure compounds in order to simplify the study. 
However, in pharmaceutical industry, most crystallization processes are with impurities. 
There is significant demand of developing novel approaches to characterize crystallization 





1.2 Research Aims 
The aims of this dissertation are to develop novel design and control approaches for 
integrated crystallization operation and systems, including combined cooling/antisolvent 
crystallization (CCAC) systems, integrated crystallization and wet milling operation, and 
crystallization systems in the presence of impurities: 
1) Modeling and simulating integrated CCAC systems in both batch and continuous 
MSMPR processes in MATLAB using population balance model (PBM) to study the 
evolution of CSD under different operation conditions, including cooling rate, antisolvent 
addition rate, batch time or residence time. Then using optimization techniques (e.g. 
sequential quadratic programming (SQP)) to optimize the operation parameters to achieve 
certain objectives, such as maximization of average crystal size, or minimization of startup 
duration in continuous MSMPR process. Finally, based on the optimization results, 
summarizing the general rules behind and developing systematic design and control 
approaches which can be used to simplify the design of CCAC experiments in batch and 
continuous MSMPR processes. 
2) Studying different ways to integrate wet milling operation with continuous 
MSMPR crystallization, including using it upstream as a continuous nucleator or 
downstream as a size reduction unit. Investigating the influences on process yield, startup 
duration, average crystal size and width of size distribution, and finding out the advantages 
and disadvantages of both the upstream and downstream applications of wet milling. Then, 
to develop a PAT-based feedback control approach for a simple continuous MSMPR 
crystallization process to achieve closed-loop controlled CSD. Finally, applying and 




continuous crystallization and wet milling processes, therefore combining the advantages 
of both wet milling and closed-loop control for continuous crystallization. 
3) Developing a novel online PAT tool to characterize the crystallization systems in 
the presence of impurities, which are difficult to monitor and control using the existing 
online or inline PAT. More specifically, studying how ultra-performance liquid 
chromatography (UPLC) can be applied as an online PAT tool in pharmaceutical 
crystallization process, what are the benefits compared to the existing PAT, and how to 
monitor crystal purity, which is the most important CQA, in real-time based on online 
UPLC. 
 
1.3 Research Contributions 
The main contributions of this dissertation include: 
1) Developed a model-based systematic design approach for unseeded CCAC batch 
process using PBM. The approach can be easily implemented in practice using automated 
lab reactors, and gives the optimal times for the start of a linear cooling profile and/or 
constant antisolvent addition rate. It can be used to produce operating surfaces based on 
which the performance of CCAC systems can be understood and operating strategies 
rapidly designed depending on the initial concentration, solvent composition and desired 
yield (Yang and Nagy, 2014). 
2) Found out the relationship and general rule between optimal batch CCAC system 
and optimal continuous MSMPR CCAC system. This is important in transferring existing 
CCAC knowledge from batch to continuous MSMPR process. In addition, it was found 




the startup duration time and waste by using dynamic startup operating profiles (i.e. 
temperature, antisolvent addition rate) instead of the typically used fixed operating 
parameters. 
3) Demonstrated the feasibility and benefits of applying advanced control approach, 
more specifically, nonlinear model predictive control (NMPC) in continuous MSMPR 
CCAC system for fast target process and product property (i.e. yield and crystal size) 
change-over and disturbance rejection. On the other hand, the simple decentralized 
proportional-integral-derivative (PID) control was proved infeasible. 
4) Integrated rotor-stator wet mill with continuous MSMPR crystallization through 
upstream and downstream applications of wet milling. The benefits of both applications on 
process yield, crystal size, width of size distribution and startup duration were identified 
compared to crystallization without wet milling. 
5) Developed a PAT-based feedback control approach, automated direct nucleation 
control (ADNC), for continuous multistage MSMPR cooling crystallization. The proposed 
approach was observed to provide quick startup, high quality control of CSD, as well as 
automated and effective disturbance suppression. 
6) Developed a novel wet milling based automated direct nucleation control 
(WMADNC) approach for continuous MSMPR cooling crystallization. It could be used to 
achieve closed-loop controlled primary nucleation or secondary nucleation kinetics, 
depending on the target particle size and whether WMADNC was used upstream or 
downstream. It not only combined the advantages of wet milling and ADNC, but also 





7) Applied UPLC as an online PAT tool in pharmaceutical crystallization for the first 
time. Three online UPLC-based applications were developed, including crystallization and 
degradation monitoring, quick calibration for UV/vis and Raman spectroscopy, and real-
time crystallization product purity monitoring. 
 
1.4 Thesis Structure 
Chapter 2 presents a literature review about pharmaceutical crystallization process 
development, including fundamentals of crystallization process, PAT, model-based and 
model-free control, batch and continuous crystallization, CCAC, integrated crystallization 
and wet milling operation, and characterization of crystallization systems in the presence 
of impurities. 
Chapter 3 introduces a PBM-based systematic design approach for unseeded CCAC 
batch process to maximize average crystal size under yield and operating constraints. 
Experimental validation of the proposed fast design approach is also presented. 
Chapter 4 describes the steady-state and startup optimization of CCAC in multistage 
continuous MSMPR crystallization process via PBM to maximize the average crystal size 
and minimize the startup duration and waste amount, by optimizing cooling rates, 
antisolvent addition rates and residence times. 
In Chapter 5, the feasibility of applying different control approaches, decentralized PID 
control or NMPC, in CCAC in two stage continuous MSMPR process is analyzed, with 




Chapter 6 shows the upstream and downstream applications of wet milling in 
continuous MSMPR cooling crystallization. The improvements on CSD, yield and startup 
duration is summarized. 
Chapter 7 describes the development of a PAT-based feedback control, ADNC, in one 
and two stage continuous MSMPR cooling crystallization process. Its benefits on set-point 
change and disturbance rejection in continuous crystallization are introduced. 
In Chapter 8, the proposed ADNC approach is integrated with wet milling technique, 
and a WMADNC approach is developed for continuous cooling crystallization. The control 
performance of WMADNC is evaluated. 
Chapter 9 presents the application of UPLC as a novel online PAT tool in 
pharmaceutical crystallization. It can be used to monitor concentration for multiple 
components, to provide quick calibration for UV/vis and Raman spectroscopy, and to 
measure crystallization product purity in real-time. 
Chapter 10 summarizes the main conclusions of this dissertation, and recommendations 




CHAPTER 2.  LITERATURE REVIEW 
2.1 Fundamentals of Pharmaceutical Crystallization 
Crystallization is a process in which randomly arranged molecules, atoms or ions 
assemble and form an ordered solid structure called crystal (Mullin, 2001). Since molecules 
that have same or similar structures are more likely to come together, crystallization is a 
good separation and purification technique. It is also an important particle technology to 
control various particulate properties of crystals, such as particle size distribution (PSD) 
(or crystal size distribution (CSD)) and crystal shape (Mullin, 2001). 
Pharmaceutical crystallization is typically carried out as suspension crystallization, 
which starts from a liquid solution that is a homogeneous mixture of the continuous phase 
called solvent and the dispersed phase called solute. Typically, the solutes in 
pharmaceutical crystallization include certain desired organic API as well as some 
impurities. Commonly used solvent include water, lower alcohols, ketones and esters, and 
so on (Mullin, 2001). One of the most important thermodynamic properties of a solution is 
solubility, which represents the equilibrated concentration of the solute in that specific 
solvent at a certain temperature. Since solubility is affected by temperature and solvent 
composition, solubility curves or solubility surfaces are built to report solubility as a 





Figure 2.1. Crystallization phase diagram. 
 
Solution is undersaturated and dissolution of existing crystals happens if the solute 
concentration is below solubility curve. The region above solubility curve is supersaturated. 
At high supersaturation above nucleation metastable limit, both formation of new crystals, 
which is called nucleation, and growth of existing crystals can occur. However, at low 
supersaturation nucleation is difficult but crystal growth still happens. The region between 
nucleation metastable limit and solubility curve is called metastable zone, in which 
crystallization is typically operated. Both thermodynamic and kinetics factors, such as 
chemical potential of nucleation and cooling rate being used can influence the position of 
nucleation metastable limit and the width of metastable zone (Davey and Garside, 2000). 
Supersaturation is the thermodynamic driving force for a crystallization process. There are 
three common ways to express supersaturation: concentration driving force, c ,  




















     (2.3) 
where c  is concentration of solute, 
*c  is equilibrated concentration or solubility. There are 
various ways to generate supersaturation in suspension crystallization, including cooling, 
antisolvent addition and solvent evaporation. Cooling or/and antisolvent addition are the 
most common approaches used in pharmaceutical crystallization. 
Nucleation and growth are the two most important kinetics in crystallization. Both of 
them are strong functions of supersaturation. There are two major types of nucleation: 
primary nucleation and secondary nucleation (Mullin, 2001). Nucleation that occurs in a 
solution which is free of the solute crystals is defined as primary nucleation. On contrary, 
secondary nucleation is defined as nucleation that happens with existing solute crystals. In 
general, primary nucleation requires higher supersaturation than secondary nucleation. In 
engineering applications, empirical equations are often used to express primary and 
secondary nucleation kinetics, 
primB  and secB  (Yang et al., 2016): 
 prim
n




sec secB k c m     (2.5) 
where primk  and seck  are primary and secondary nucleation rate constants, primn  and secn  




is the second moment of the CSD (Frawley et al., 2012). For size independent crystal 
growth, the following empirical equation is often used to express growth kinetics: 
 g
gG k c    (2.6) 
 where G  is growth rate, gk  is growth rate constant and g  is the growth order. primk , seck , 
gk  sometimes are used as constant numbers, but sometimes are expressed as Arrhenius 
equations which depend on temperature and nucleation or growth activation energy 
(Frawley et al., 2012). 
 
2.2 Process Analytical Technology (PAT)1 
In 2004, the U.S. Food and Drug Administration (FDA) published the guidance for 
pharmaceutical industry about process analytical technology (PAT), in which PAT was 
considered as “a system for designing, analyzing, and controlling manufacturing through 
timely measurements (i.e., during processing) of critical quality and performance attributes 
of raw and in-process materials and processes, with the goal of ensuring final product 
quality” (FDA, 2004). In terms of pharmaceutical crystallization processes, the CQAs of 
the final product typically include chemical purity, polymorphic form, CSD and crystal 
shape (King et al., 2015; McGlone et al., 2015; Park et al., 2016; Zhang et al., 2015). The 
CQAs are affected by important process parameters such as the concentration and 
supersaturation profiles of the API and impurities. Many PAT tools have been developed 
in recent decades to monitor and control CQAs and important process parameters inline, 
                                                 
1  Reproduced with permission from Cryst. Growth Des., submitted for publication. Unpublished work 




online, atline or offline in pharmaceutical crystallization (Simon et al., 2015). In inline 
analyses, the sample interface is located inside the process therefore separate sampling 
system is not needed (Hassell and Bowman, 1998). On the other hand, online analyses 
require automated sampling and transport through a sample line to an automated analyzer, 
whereas atline or offline analyses need manual sampling with transport to analyzer (Hassell 
and Bowman, 1998). Focused beam reflectance measurement (FBRM) was a laser 
technique extensively used in pharmaceutical crystallization as an inline PAT tool to 
provide in situ measurement of crystal chord length distribution (CLD) that reflects CSD 
(Li et al., 2013, 2014; Peña and Nagy, 2015; Yang and Nagy, 2014; Yang et al., 2015d, 
2015e, 2016). Inline video microscopy system such as particle vision and measurement 
(PVM) are techniques that can record crystal appearance (i.e. shape and size) in real-time 
(Acevedo and Nagy, 2014; Acevedo et al., 2015; Borsos et al., 2016). Raman spectroscopy 
with immersion optics has been developed to measure crystal polymorphic form inline 
(Simone et al., 2014a). There are also some important atline or offline spectroscopy 
techniques such as mid-infrared (IR), near infrared (NIR), Raman and x-ray diffraction 
(XRD), which can quantify polymorphs and crystallinity (Steen et al., 2015; Barba et al., 
2013). Inline or online PAT are favorable because they can avoid manual sampling errors 
and allow real-time closed-loop process control (Barrett et al., 2010; Chew et al., 2007; 
Khan et al., 2011; Ma and Wang, 2012). Simone et al. developed a composite sensor array 
(CSA) based on multiple inline PAT including Raman, NIR, and attenuated total 
reflectance ultraviolet/visible (ATR-UV/vis) spectroscopy, FBRM and PVM for an 
automated intelligent decision support and control system (Simone et al., 2015b). The 




automated feedback control. Table 2.1 presents some references about application of inline 
PAT for various purposes, such as monitoring of crystallization product, characterization 
of polymorphic transformation, determination of nucleation and growth kinetics. 
 
Table 2.1 References about applications of PAT in crystallization 
PAT Property measured Reference 
FBRM Particle chord counts, CLD Barrett and Glennon, 2002; Kempkes et al., 2008; Li et al., 2013, 
2014; Peña and Nagy, 2015; Saleemi et al., 2012a, 2012b; 
Simone et al., 2014b, 2015b, 2015c; Su et al., 2010; Zhao et al., 
2013. 
PVM Size and shape Acevedo et al., 2015; Barrett and Glennon, 2002; Barrett et al., 
2010; Borsos et al, 2016; Kempkes et al., 2008; Simon et al., 
2009b; Simone et al., 2015b; Su et al., 2010; Zhao et al., 2013. 
UV/vis Concentration Aamir et al., 2010; Bakar et al., 2009; Saleemi et al., 2012b; 
Thompson et al., 2005; Simone et al., 2014b, 2014c, 2015a, 
2015b, 2015c. 
Raman Polymorph, concentration Simone et al., 2014a, 2014b, 2014c, 2015a, 2015b; Su et al., 
2010; Zhao et al., 2013. 
 
2.3 Model-Based and Model-Free Control2 
In general, crystallization process can be controlled via either model-based or model-
free approaches (Nagy et al., 2008b, 2013). The applications of both approaches in batch 
crystallization have been studied in depth in literature. In model-based approaches, 
typically a PBM is used to describe the evolution of the CSD in the crystallization process. 
By applying optimization techniques, open-loop optimal temperature or/and antisolvent 
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addition profiles could be obtained to produce desired CSD without violating equipment 
limitations (e.g. maximum/minimum temperature, cooling rate or antisolvent addition rate) 
or productivity/yield constraint.  Plenty of papers have shown the benefits of using model-
based optimization and offline calculated optimal operating profiles in unseeded/seeded 
batch/continuous cooling and/or antisolvent crystallization (Mullin and Nyvlt, 1971; 
Rawlings et al., 1993; Vetter et al., 2014; Worlitschek and Mazzotti, 2004; Xie et al., 2001; 
Yang and Nagy, 2015c; Zhang and Rohani, 2003). 
In addition, more advanced model-based approaches that solve the open-loop 
optimization repeatedly, such as model predictive control (MPC) has been applied in batch 
crystallization process (Hermanto et al., 2009; Nagy and Braatz, 2003; Kalbasenka et al., 
2007). MPC uses the mathematical model and real-time measurements to optimize the 
current operating curve, based on the predicted future behavior of the system. For systems 
of high complexity and nonlinearity, nonlinear model predictive control (NMPC) is used 
instead of linear model predictive control (LMPC). Hermanto et al. utilized NMPC strategy 
to control polymorphic transformation in a batch crystallization process (Hermanto et al., 
2009). It was proved to be more robust than other existing control strategies like 
temperature control or concentration control. A robust extended Kalman filter-based 
NMPC framework was developed by Nagy and Braatz for batch crystallization processes 
(Nagy and Braatz, 2003). The proposed NMPC approach considerably enhanced robust 
performance as compared with open-loop optimal control. Although these model-based 
approaches require significant time and engineering effort to develop the model, and have 




process understanding, provide theoretically optimal recipe, and require much smaller 
number of experiments than statistical experimental design (Nagy et al., 2008b).  
Model-free (or direct design) approaches such as supersaturation control (SSC) (Nagy 
et al., 2008a; Nagy and Aamir, 2012; Gron et al., 2003), direct nucleation control (DNC) 
or automated direct nucleation control (ADNC) (Abu Bakar et al., 2009; Saleemi et al., 
2012a, 2012b) are methodologies that maintain the operating curve within the metastable 
zone to avoid nucleation or to generate controlled dissolution. They are based on the direct 
use of PAT tools (e.g. FBRM, UV/Vis, IR spectroscopy) in closed-loop control of 
crystallization processes. Gron et al. developed a closed-loop supersaturation control 
approach of batch crystallizer using in-process ATR-FTIR spectroscopy (Gron et al., 2003). 
This strategy could produce crystals of desired product properties, notably uniformity in 
crystal size and shape. Nagy et al. investigated a model-free concentration control approach 
to maintain the supersaturation within the metastable zone in batch cooling crystallization 
(Nagy et al., 2008a). It showed lower sensitivity to disturbances than model-based 
temperature control approach. Abu Bakar et al. implemented a DNC approach to directly 
control the amount of nuclei present using measurements taken by FBRM in closed-loop 
control framework through heating/cooling and addition of solvent/antisolvent (Abu Bakar 
et al., 2009). It was found DNC approach resulting in larger crystal size than uncontrolled 
crystallization experiments. Saleemi et al. developed an ADNC approach to automatically 
detect secondary nucleation and accidental seeding in the system and remove fines in situ 
(Saleemi et al., 2012a, 2012b). These model-free approaches only require basic 
crystallization concepts and simple mathematical tools without any modeling effort. They 




the set-point operating profiles are suboptimal and typically chosen arbitrarily or by trial-
and-error (Fujiwara et al., 2005). The model-free feedback control approaches are aligned 
with the novel quality-by-control (QbC) concept which allows larger applicable design 
space and more robust process operation than the commonly used quality-by-design (QbD) 
approaches (Yang et al., 2015e). 
   
2.4 Batch and Continuous Crystallization3 
Crystallization is implemented as a batch operation for most of the time in 
pharmaceutical industry. Batch crystallization has large operation flexibility and only 
requires a short development time (Ward et al., 2006). However, in batch crystallization 
the operating conditions change with time, resulting in control difficulty and batch to batch 
inconsistency (Alvarez et al., 2011). The process and equipment efficiency is also limited 
in batch operation (Alvarez et al., 2011). These intrinsic disadvantages of batch 
crystallization have strongly motivated the development of continuous crystallization 
systems during the recent decade. Continuous crystallization is operated at steady-state, in 
which crystals of consistent purity, yield, CSD and polymorphic form can be produced. 
Therefore, in a long run continuous crystallization can have better quality consistency, 
process and equipment efficiency, and productivity as compared with batch crystallization 
(Alvarez et al., 2011; Quon et al., 2012; Zhang et al., 2012). 
Several types of continuous crystallizers have been developed, including mixed 
suspension mixed product removal (MSMPR) crystallizer, plug flow crystallizer (PFC) and 
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oscillatory baffled crystallizer (OBC) to name only a few. Compared to the other two, 
MSMPR crystallization processes are more frequently applied in industrial crystallization 
since they provide a smaller technology change from batch and are simpler to operate 
(Vetter et al., 2014). MSMPR crystallizer is an ideally well-mixed vessel that has feed 
solution continuously entering in and product slurry continuously withdrawn. The output 
slurry is assumed to have exactly the same composition as the vessel content. It can be used 
in various configurations, including single stage, multistage, or with recycle loops 
(Acevedo et al., 2016; Alvarez et al., 2011; Quon et al., 2012; Vetter et al., 2014; Wong et 
al., 2012; Zhang et al., 2012). It is operated at steady-state, which could be close to batch 
equilibrium condition by increasing the number of stages. As a result, it is relatively easy 
to convert batch knowledge into continuous MSMPR crystallization systems (Wong et al., 
2012). In addition, it has large tolerance for high suspension density, and can be used for 
crystallization of slow growing crystals which require long residence times (Quon et al., 
2012). Cooling, or antisolvent addition, or both could be applied to generate 
supersaturation at a certain MSMPR crystallization stage. Vetter et al. modeled MSMPR 
cascade crystallization process using PBM (Vetter et al., 2014). Cooling only 
crystallization, antisolvent addition only crystallization, and CCAC were used as three case 
studies, in which the particle size attainable regions of MSMPR cascade crystallizers of 
different number of stages were obtained and compared with batch crystallizer and PFC. 
Quon et al. implemented and optimized a two stage MSMPR cascade crystallization 
process for continuous reactive cooling crystallization of aliskiren hemifumarate (Quon et 
al., 2012). Crystals of both high yield and purity were obtained. Alvarez et al. implemented 




using cooling to generate supersaturation (Alvarez et al., 2011). A PBM was developed in 
the same work, and used to optimize crystal size, yield and purity, as well as to obtain 
crystallization kinetic parameters.  Wong et al. constructed two continuous single stage 
MSMPR crystallizers with recycle loop for cooling crystallization and CCAC (Wong et 
al., 2012). They experimentally demonstrated the feasibility and potential advantages (e.g. 
high yield) of having recycle loop in single stage MSMPR crystallizer.  A continuous 
CCAC process using two stage MSMPR cascade crystallizer was implemented by Zhang 
et al., and was experimentally validated to be able to well control CSD, yield and purity 
(Zhang et al., 2012). PFC is another common approach to perform continuous 
crystallization. In PFC, supersaturation is generated by cooling or antisolvent addition 
along the tube to promote nucleation and growth (Ferguson et al., 2012). One of the major 
challenges in PFC is to keep crystals suspended (Vetter et al., 2014). Typically, a high flow 
rate is necessary, and a long tube length is required to achieve the desired residence time. 
As a result, PFC is usually used for fast growing compounds with low residence times. It 
usually produces small crystals with narrow size distribution (Quon et al., 2012). Alvarez 
and Myerson applied static mixing elements into the antisolvent crystallization of 
ketoconazole in a PFC (Alvarez and Myerson, 2010). Eder et al. developed a PFC with 
continuous seeding for cooling crystallization of aspirin in ethanol (Eder et al., 2010). In 
addition, Lawton et al. presented a continuous OBC, which behaves similar as ideal PFC 





2.5 Combined Cooling/Antisolvent Crystallization (CCAC) System4 
The fundamental driving force for crystallization is supersaturation, which typically is 
generated by cooling or antisolvent addition in pharmaceutical industry. Significant 
amount of work exist that studies the design and control problem of cooling only or 
antisolvent addition only crystallization (Aamir et al., 2010; Hermanto et al., 2010; Ma and 
Wang, 2012; Nagy and Braatz, 2012; Nagy et al., 2013; Nowee et al., 2008). Besides using 
these two approaches independently, CCAC is another technique commonly used in the 
pharmaceutical industries. Compared with cooling or antisolvent addition only 
crystallization, the major advantage of CCAC is the higher yield, due to the extra driving 
force of this combination (Sheikhzadeh et al., 2008). The final product properties (e.g. 
CSD) can also be improved if the process can be controlled well (Nagy et al., 2008b). In 
addition, since solvent/antisolvent ratio can also have effect on crystal shape and 
polymorphic form, CCAC can provide extra control on multiple crystal properties 
simultaneously (Yang and Nagy, 2014). 
Nagy et al. have firstly presented a comparative overview about the control problem of 
CCAC through both model-free and model-based framework (Nagy et al., 2008b). In this 
work the optimal simultaneous cooling and antisolvent addition operating profiles in terms 
of various single objectives were obtained through model-based optimization. Both the 
simulation and experimental validation results indicated that the CCAC approach can yield 
better crystal quality than the cooling or antisolvent only processes. Trifkovic et al. showed 
an experimental study of offline and online optimal control for a CCAC process (Trifkovic 
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et al., 2009). A neuro-fuzzy logic controller was also developed by the same group to 
increase the theoretical yield and control the supersaturation through combination of 
cooling and antisolvent addition (Sheikhzadeh et al., 2008). Recently an operating strategy 
with combined cooling and antisolvent addition was utilized to produce consistent CSD 
(Hermanto et al., 2012). Lindenberg et al. determined nucleation and growth kinetics of 
aspirin (acetylsalicylic acid) using in situ monitoring techniques (Lindenberg et al., 2009). 
In the same work, a strategy with constant cooling and antisolvent addition rate under the 
same feeding time for seeded CCAC process was discussed, indicating that it should be 
favored as compared to processes where the antisolvent was added all at once at the 
beginning or end of the cooling ramp. 
 
2.6 Integrated Crystallization and Wet Milling Operation5 
Traditionally in crystallization design large and uniform crystals are desired in order to 
facilitate downstream operations, such as filtration and drying. But small and uniform 
crystals are also of great interest due to their high dissolution rate and bioavailability, 
therefore may be used directly in formulation so that downstream processes like milling 
and granulation can be avoided. One approach to generate small and uniform particles is 
to use impinging jet mixer (Hacherl et al., 2003; Johson and Prud’homme, 2003; Kamahara 
et al., 2007). The residence time inside the impinging jet mixer can be manipulated and 
either crystalline or amorphous particles can be obtained. However typically the jet mixer 
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requires two streams that have similar volumes therefore it is mainly applied in antisolvent 
or reactive crystallization (Kamahara et al., 2007). Wet mill is another commonly used 
approach that can reduce particle size and size distribution, as well as normalize API 
physical properties in pharmaceutical industry (Burcham et al., 2008; Harter et al., 2013). 
Harter et al. investigated the scale up approach of terminal particle size and milling time 
required to achieve target particle size in wet mill batch operation (Harter et al., 2013). 
Kougoulos et al. compared the PSD obtained in high shear wet mill with other particle 
engineering techniques such as sonocrystallization and dry impact milling after a 
conventional batch cooling crystallization (Kougoulos et al., 2011). Engdtrom et al. 
integrated toothed rotor-stator wet mills with batch cooling crystallizers in a recycle loop 
across lab and pilot plant scale (Engstrom et al., 2013). It was found that the normalized 
energy imparted by the wet mills could be correlated to the particle size reduction by using 
an energy factor and a probability factor. Kamahara et al. coupled a high-speed rotor-stator 
wet mill with a semibatch antisolvent crystallization process using a recycle loop to achieve 
controlled secondary nucleation under high shear environment during crystallization and 
successfully scaled up this approach (Kamahara et al., 2007). As compared to the 
traditionally used dry milling technique which follows crystallization, these integrated wet 
milling and crystallization techniques have the advantages of achieving process 
intensification (i.e. eliminated separate unit operation of milling), better API chemical and 
physical stability, as well as safety (e.g. reduced exposure, prevented API dust explosions) 
(Burcham et al., 2008). In addition, according to the literature, both primary and secondary 
nucleation rates increase dramatically under high shear environment (Allen et al., 2008; 




rotor-stator wet mill downstream, potentially it may also be used upstream as a continuous 
in situ seed generation tool for crystallization processes. This continuous wet seeding 
technique can have advantages on seed quality consistency as well as safety compared with 
commonly used dry seeding technique. But the upstream application of continuous wet 
milling in pharmaceutical crystallization has not been studied in literature yet. 
 
2.7 Characterization of Crystallization System in the Presence of Impurities6 
The development of PAT that can provide fast and accurate inline or online 
concentration measurement is of great importance in the characterization, design and 
control of pharmaceutical crystallization processes. Inline spectroscopy techniques have 
been extensively reported to monitor concentration in crystallization processes. Cornel et 
al. demonstrated the quantitative application of in situ attenuated total reflectance Fourier 
transform infrared (ATR-FTIR) and Raman spectroscopy with multivariate analysis and 
principal component analysis (PCA) to monitor liquid composition during cooling 
crystallization, precipitation and polymorphic transformation of L-glutamic acid (Cornel 
et al., 2008). Zhou et al. used ATR-FTIR spectroscopy and a partial least square (PLS) 
model for in situ concentration measurement and closed-loop control of supersaturation in 
antisolvent crystallization of paracetamol (Zhou et al., 2006). Thompson et al. measured 
solute concentration in the crystallization of an important organic compound using ATR-
UV spectroscopy, a calibration curve, a PLS temperature correction model and orthogonal 
signal correction (Thompson et al., 2005). Some key advantages of spectroscopic 
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concentration analysis (e.g. ATR-FTIR, ATR-UV, Raman) are that it is typically rapid 
(<30 seconds per measurement) and there are many commercially available probe type 
tools for in situ measurement. There are several disadvantages of spectroscopy approaches, 
however, that strongly limit their applications in pharmaceutical manufacturing. First, 
spectroscopic techniques are challenging to use in processes that contain multiple 
components, especially for structurally related chemicals due to their overlapped spectra. 
Many industrial pharmaceutical crystallization processes contain more than one 
component. For this and other reasons, knowledge of chemometrics is important to process 
the spectroscopy data in order to obtain accurate concentration values. Commonly used 
statistical and mathematical tools include data preprocessing techniques (e.g. spectral 
normalization, linear baseline correction, standard normal variate, multiplicative scatter 
correction) and multivariate data analysis (e.g. PCA, PLS) (Cornel et al., 2008). This is 
also because spectroscopic signals, for example Raman, can be influenced by not only 
liquid composition but also solid density, particle size, temperature, etc. Sometimes 
standard univariate approaches based on peak height or area, which are much simpler than 
chemometrics techniques, are also feasible. Saleemi et al. were able to obtain good 
concentration measurement using ATR-UV/vis spectroscopy and a simple non-linear 
calibration model based on single wavelength data (Saleemi et al., 2012a, 2012b). Due to 
the large number of factors that can influence spectroscopic signals and the limitation of 
concentration measurement, a long time (e.g. a week) is typically required in the standard 
calibration approach in order to collect data at different concentrations, temperatures, etc. 
to train the calibration model (Saleemi et al., 2012b). In addition, the spectroscopy 




none-transferable or in need of recalibration due to instrument drifting. One would even 
need to re-calibrate every few weeks or months due to instrument drifting. Finally, probe 
based PAT tools such as ATR-UV/vis, ATR-FTIR, Raman, FBRM, and PVM, are not 
accurate in the presence of fouling, which is a very common phenomenon in crystallization 
processes. 
High-performance liquid chromatograph (HPLC) is widely used to measure analyte 
concentration in pharmaceutical analysis because it can provide very accurate results for 
multiple components (i.e. API and impurities) using simple linear calibration models based 
on the peak area of each component. HPLC often requires up to half an hour per 
measurement which significantly limits its use for process monitoring. Revolutionary 
advances in chromatography columns and instrumentation, such as reduced particle size, 
higher pressure capabilities and minimal system dispersion led to the introduction of ultra-
performance liquid chromatography (UPLC) in 2004. Compared to HPLC, UPLC offers 
improved resolution and sensitivity, lower solvent consumption, and analysis times of only 
a few minutes (Swartz, 2005). Together, these improvements make UPLC very attractive 
for PAT applications. In addition, there are a number of different ways to calibrate HPLC 
or UPLC, such as single external standard, calibration curve or internal standard, that are 
all simpler than the spectroscopy calibration described earlier because chromatographic 
peak area is typically a linear function of analyte concentration. Therefore, online UPLC 
would be a good replacement for spectroscopy when the characterization of crystallization 
systems in the presence of impurities is required. 
HPLC and UPLC have been widely used in the analysis of pharmaceutical products. 




regulatory requirements. Purity, however, is mainly measured atline in literature by 
manually taking samples, filtering, washing, diluting and running HPLC atline (Alvarez et 
al., 2011; Li et al., 2016; Simone et al., 2015c). This commonly used atline purity 
measurement method is inconvenient, incompatible with real-time process control, and 
sometimes inaccurate due to the manual sampling errors. As a result, the development of 
an online crystallization product purity measurement approach is extremely important for 
crystallization systems in the presence of impurities. 
 
2.8 Summary on Literature Review 
This chapter presents a literature review for recent development in pharmaceutical 
crystallization, including fundamentals of crystallization process, PAT, model-based and 
model-free control, batch and continuous crystallization, CCAC, integrated crystallization 
and wet milling operation, and characterization of crystallization systems in the presence 
of impurities. In general, simple crystallization operation and systems have been 
extensively studied in literature, whereas there is a lack of investigation about more 
complex and integrated crystallization operation and systems, including CCAC systems, 





CHAPTER 3. MODEL-BASED SYSTEMATIC DESIGN APPROACH FOR 
UNSEEDED COMBINED COOLING/ANTISOLVENT CRYSTALLIZATION7 
3.1 Introduction 
The fundamental driving force for crystallization is supersaturation, which can be 
generated by cooling or antisolvent addition. Besides using these two supersaturation 
generation approaches independently, CCAC is another technique, often applied in the 
pharmaceutical industries. Despite the relatively widespread industrial use of CCAC, the 
modeling, design and control of these systems have not been studied in depth in literature 
yet, motivating the growing interest in this area in recent years. 
The goal of this work is to develop a systematic approach for unseeded batch CCAC 
processes using a model-based simulation and optimization framework. The approach is 
based on the PBM of the CCAC solved using the method of moments (Nagy et al., 2008b). 
Under fixed batch time, this model is then used to optimize the cooling time and antisolvent 
feeding time, which both have constant rates, to obtain suboptimal but easily 
implementable operating trajectories.
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Multiple scenarios with different initial solution conditions (initial temperature, 
solvent/antisolvent ratio) were analyzed and a CCAC design surface was generated that 
can be used to provide a map that indicating whether the process was controlled by 
antisolvent addition, cooling or both, and could also be used to estimate operating 
procedures quickly for different initial conditions that can provide a desired product 
property (e.g. mean size) under fixed batch time and yield requirements. The simulation 
results were also validated through experiments, performed in an automated laboratory 
crystallizer. Finally, the suboptimal trajectories obtained by our methodology were 
compared to the optimal trajectories obtained by full optimization of nonlinear trajectory. 
The methodology that created the CCAC design surface for simplified operating 
trajectories could significantly reduce the number of experiments required for the design 
of unseeded CCAC process. The model system used in the evaluation studies was aspirin 
(acetylsalicylic acid) in ethanol-water mixture. 
 
3.2 Mathematical Modeling 
The population balance equation (PBE) (Ramakrishna, 2000; Randolph, 1988) for a 
batch or semi-batch crystallizer in which crystal growth is size independent, crystal shape 
is uniform, crystal breakage or aggregation is negligible can be written as: 
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  (3.1) 
where n  is the volumetric number density(#/m3), L  is the characteristic crystal size (m), 




For a semi-batch crystallizer where antisolvent addition is applied and total volume is 
time-varying, a redefined number density ( , )n L t  can be used to simplify equation (3.1) 
(Nagy et al., 2008b): 
    , , ( )n L t n L t V t   (3.2) 
where V  is the total volume of mother liquor (m3). 
The corresponding redefined PBE becomes: 
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The above PBE was solved using the method of moments. The j th moment of ( , )n L t
is defined as (Nagy et al., 2008b): 
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where 0  is the total number of crystals in the crystallizer, 1 0/   is the number-average 
mean size. Assuming the nuclei formed through primary nucleation in unseeded batch 
crystallizer has zero size, the ordinary differential equations (ODEs) of each moment can 
be written as (Nagy et al., 2008b): 
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The mass balance equations used in the model for the semi-batch crystallizer is derived 
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where 
liqm  (g) is the mass of mother liquor mixture, wF  (g water/min) is the flow rate of 
antisolvent water, sc  is the solute concentration (g solute/g solvent), c  is the crystal 
density (g/cm3), vk  is the crystal volume shape factor, ethanolc  is the ethanol concentration 
(g ethanol/g solvent), 
liq  is the solvent mixture density (g/cm
3). In this study, the values 
of c  and vk  are fixed at 1.4 g/cm
3, / 6 , respectively. 
Different empirical or semi-empirical equations are used in the literature to express 
nucleation and growth kinetics, which usually depend on the supersaturation and the 
temperature. In this chapter, the growth rate and primary nucleation rate of aspirin in 
ethanol-water mixture are expressed by empirical equations (Lindenberg et al., 2009): 
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where S  is the supersaturation ratio, c  is the solute concentration (g solute/g solvent), 
*c  
is the solubility (g solute/g solvent) at a certain temperature and ethanol concentration, 1Gk
, 2Gk , 3Gk , 1Bk , 2Bk , 3Bk  are empirical parameters from literature (Lindenberg et al., 
2009), as given in Table 3.1. 
 
Table 3.1. Growth and nucleation kinetic parameters of aspirin in ethanol-water mixture 
measured by Lindenberg et al., 2009. 
 Parameters Values 
Growth 
1Gk   
4 13.21 0.18 10 m s     
2Gk   
4 12.58 0.14 10 J mol    
3Gk   1.00 0.01  
Nucleation 
1Bk   
21 3 11.15 0.51 10 m s    
2Bk   
4 17.67 0.11 10 J mol    
3Bk   0.16 0.01  
 
There have been a variety of different approaches to calculate the solubility data at a 
certain temperature and ethanol concentration using scattered experimental data. The 
mathematical approach in this work is biharmonic interpolation (Sandwell, 1987). Table 
3.2 presents some experimental solubility data determined by ATR-FTIR from literature 
(Lindenberg et al., 2009). A surface described by biharmonic interpolation via the 





Table 3.2. Solubility of Aspirin 
*c  (g solute/kg solvent) from Lindenberg et al., 2009. 
waterc [g water/g solvent] ethanolc [g ethanol/g solvent] T [℃] 
*c [g solute/kg solvent] 
0 1.00 25 237.9 
0 1.00 35 378.4 
0 1.00 50 648.4 
0.10 0.90 25 283.2 
0.10 0.90 35 419.1 
0.10 0.90 50 689.2 
0.25 0.75 25 266.6 
0.25 0.75 35 395.3 
0.25 0.75 50 679.1 
0.40 0.60 25 186.2 
0.40 0.60 35 304.8 
0.40 0.60 50 570.8 
0.55 0.45 25 87.9 
0.55 0.45 35 149.5 
0.55 0.45 50 377.0 
0.75 0.25 25 16.2 
0.75 0.25 35 32.9 
0.75 0.25 50 101.6 
 
 
Figure 3.1. Solubility surface of aspirin in ethanol-water mixture. The circles are solubility 






































3.3 Experimental Section 
Acetylsalicylic acid (>99%, Sigma-Aldrich, USA), ethanol (pure, 200 pf, KOPTEC, 
USP Grd) and deionized water were used in all tests. The experiments were carried out in 
Easymax synthesis workstation (Mettler Toledo, USA), including an Easymax 102 reactor 
block, a 100 mL teflon-covered round-bottom glass reactor, an overhead glass stirrer, an 
external solid state thermostat and a SP-50 dosing unit. Water was used as antisolvent and 
was fed into the reactor by the SP-50 dosing unit. The iControl Easymax 4.2 software 
(Mettler Toledo, USA) was used to design and control all experimental procedures, 
including the control of the reactor temperature, cooling rate, cooling time, dosing rate, 
dosing time, and stirring rate. Additionally, the reactor was equipped with a FBRM G400 
probe (Mettler Toledo, USA) for in situ measurements of the CLD, the total counts and the 
square weight mean chord length (SWMCL) of the crystals in the slurry, and was connected 
with iC FBRM 4.3 software (Mettler Toledo, USA) for data analysis. The FBRM data was 
measured every 10 seconds and averaged at 20 seconds interval. All experiments were 
carried out at a stirring rate of 400 rpm. The setup is shown in Figure 3.2. 
 




All crystallization experiments were unseeded. The initial solubility data is calculated 
via 2D interpolation from the solubility surface constructed from experimental data as 
described before, according to the initial temperature and ethanol concentration, which are 
(48.5℃, 55% ethanol). The initial total mass of solvent and supersaturation ratio are fixed 
at 25g and 1.03, respectively, from which the initial mass of aspirin, ethanol and water are 
calculated. The solution was first heated to 5 degrees above the desired initial temperature 
and stabilized for 15 minutes. Then it was slowly cooled to the desired initial temperature 
for the controlled temperature profile and stabilized for 5 more minutes before the 
crystallization experiment began. The FBRM data was collected during the experiment. 
Then after the 30 minutes batch time ended, the experiment was stopped immediately and 
slurry samples were taken out through a pipet and quickly filtered. The crystal samples 
were dried in hood and kept in sealed tube. A Nikon SMZ1500 microscope was used to 
take images of the crystal samples. 
 
3.4 Results and Discussion 
3.4.1 CCAC Design Through the Optimization of Operating Procedures With Constant 
Cooling and Antisolvent Addition Rates 
In order to make the cooling and antisolvent addition profiles easy to implement in 
industrial process, the cooling rate and antisolvent addition rate are kept constant in this 
study. The trajectories computed this way will be suboptimal compared to allowing time-
varying cooling and antisolvent addition rates, but are easily implementable in industrial 
crystallization systems. The control problem of computing these operating trajectories can 




temperatures, ethanol concentrations, as well as the batch time are fixed at certain desired 
values. The optimization variables are the times when the cooling profile starts and ends (
1t and 2t , respectively) as well as the times when the antisolvent feeding starts and stops (
3t , and 4t , respectively), as shown in Figure 3.3. The optimization problem can be written 
as follows: 
 
1 2 3 4
. . . 1 0
, , ,
max { ( ) ( ) / ( )}n m s n batch batch batch
t t t t
J L t t t      (3.15) 
subject to: 
model equations (3.5) to (3.14) 
 1 2 3 40 , , , batcht t t t t        (3.16) 
 1 2t t   (3.17) 
 3 4t t   (3.18) 
    , ,(0) , ( ) , 0 ,liq liq initinitial batch final ial liq liq finalbatchT T T t T m m tm m        (3.19) 
where 1 2 3 4, , ,t t t t    are cooling start and end times, antisolvent start and end times, 
respectively, batcht  is the batch time, which is fixed at 30 minutes. initialT , finalT , ,liq initialm , 
,liq finalm  
are the predetermined temperatures and masses of mother liquor for the initial and 
the final solutions. The inequality constraints from (3.16) to (3.18) limit the operation time 
of cooling and antisolvent addition in the proper range. The last equality constraints are 
used to fix both the initial and the final conditions of the solution at desired points. The 
objective function J  is some desired crystal properties at the end of batch. In this study the 






Figure 3.3. Schematic of CCAC process with constant cooling rate and antisolvent addition 
rate. 1 2 3 4, , ,t t t t    
are cooling start time and end time, antisolvent start time and end time, 
respectively. 
 
Multiple scenarios with different initial conditions but same initial solubility and 
concentration were evaluated to obtain the suboptimal trajectories (Figure 3.4). Especially, 
two scenarios were analyzed in detail, (i) Scenario 1 (S1), when the system followed the 
trajectory from point A (40.0 ℃, 75% ethanol) to point C (25 ℃, 40% ethanol) in the phase 
diagram, and (ii) Scenario 2 (S2), in which the process followed on operating curve from 
a different initial point B (48.5 ℃, 55% ethanol) to the same final point C (25 ℃, 40% 
ethanol) in the phase diagram (as shown in Figure 3.4). The initial points A and B were 
selected so that point A locates in an area of the solubility surface that has high sensitivity 
for temperature change but low sensitivity for change in antisolvent concentration, whereas 
point B locates in an area of the phase diagram where the solubility surface shows high 
sensitivity to change in antisolvent concentration but low sensitivity for temperature 
change. In addition, points A and B have the same solubility, indicating that both 






















































trajectories, S1 and S2, provide the same concentration change. Thus, S1 and S2 are two 
typical scenarios in a CCAC process and are comparable with each other. 
 
Figure 3.4. Suboptimal trajectories for S1, S2, and scenarios with other initial conditions. 
 
Table 3.3 and Figure 3.5 present the suboptimal cooling times and antisolvent feeding 
times and corresponding operating profiles for S1 and S2. Figure 3.6 shows how the 
supersaturation ratio, 0 ( )t  
and concentration change with time.  
 
Table 3.3. Optimal cooling time, antisolvent feeding time and final crystal properties for 
S1 and S2 obtained through optimization. 
 S1 S2 
1 [min]t   0.0 17.2 
2 [min]t   30.0 30.0 
3 [min]t   12.9 0.0 
4 [min]t   30.0 14.7 
[ ]nL m  529 527 





Figure 3.5. Suboptimal operating curves for (a) S1 and (b) S2. 
 
Figure 3.6. (a) Suboptimal supersaturation ratio, 0 ( )t  
for S1 (solid line) and S2 (dotted 
line); (b) suboptimal concentration trajectories for S1 (solid line) and S2 (dotted line). 
 
For both S1 and S2, the supersaturation ratios remain high in the first 15 minutes to 
promote nucleation in the system, and then decrease to a low but relatively constant level 
to maintain growth (see Figure 3.6(a)). In addition, it can be found that the primary 
nucleation was induced by cooling only in S1, whereas was induced by antisolvent only in 
S2 (see Figure 3.5 and Figure 3.6(a)). Trajectory S1 gives slightly larger particles than S2 
(see Table 3.3) since in this trajectory nucleation occurs sooner (longer time available for 



































































































































































































growth) and the number of particles is lower (see Figure 3.6(a)) although the initial and 
final concentrations in both cases are the same and the concentration trajectories are 
significantly different (see Figure 3.6(b)). Since nucleation occurs later for S2 a larger 
number of particles are required to achieve similar final concentration in shorter time as 
for S1. 
Several other trajectories, which all have the same initial solubility and concentrations 
as S1 and S2, were also computed using a similar optimization framework but starting from 
different initial conditions in the phase diagram as shown in Figure 3.4. From these 
trajectories, it is easy to recognize that, in cooling sensitive regions, such as point A, 
cooling first strategy, or cooling induced nucleation is preferred. However, in antisolvent 
sensitive region, like point B, antisolvent first strategy or antisolvent induced nucleation is 
preferred. This phenomenon can be explained as an early primary nucleation, which needs 
relatively high supersaturation, is quite desirable in an unseeded batch crystallization to 
ensure that there is longer time for growth. The concepts of temperature-controlled 
operating region and antisolvent-controlled operating region were first introduced by Nagy 
et al., 2008b, but the present work provides a systematic analysis and application of these 
into CCAC design and control practice.  
In the case of the trajectories obtained for scenarios S1 and S2 it can be seen that when 
cooling first is preferred, as expected cooling must start at 0 minute to ensure an early 
nucleation, and antisolvent should stop at the end of batch to maintain a maximum growth. 
In other words, for cooling first strategy 1t  and 4t  can be fixed at 0 and 30 minute 




0 minute respectively. From the various additional operating trajectories obtained for 
different initial conditions presented in Figure 3.4, the same general conclusions can be 
achieved. Consequently, the operating trajectories can be simplified for the two strategies 
to have only two optimization variables each, as shown in Figure 3.7. In these simplified 
cases the effect of the two design parameters ( 2t  and 3t  for cooling first, 1t  and 4t  for 
antisolvent first) on the desired final product quality (expressed as the mean size nL ) can 
be represented as an operating map using model-based simulation. 
 
Figure 3.7. Schematic of (a) cooling first and (b) antisolvent first strategy. 1t , 2t , 3t  and 4t  
are cooling start time and end time, antisolvent start time and end time, respectively. 
 
3.4.2 CCAC Design Using a Simulation-Based Operating Map 
Because the suboptimal trajectories belong to either cooling first or antisolvent first 
strategies, the optimization problem discussed in the previous section may be converted 
into a simple simulation based evaluation problem. The key advantage of this approach is 
that a generic operating map can be developed that can be used for better understanding of 

































































































the crystallization operating conditions that will affect a particular crystal property and can 
be used for the rapid design of an operating strategy that will produce for example a desired 
mean crystal size and yield, without the requirement of performing model based 
optimizations. 
As shown in Figure 3.7, the operating trajectories of cooling first strategy can be found 
by simulating the CCAC processes when both 2t  and 3t vary from 0 to 30 minute. Similarly, 
the operating trajectories for the antisolvent first strategy can be obtained by simulations 
by varying both 1t  and 4t from 0 to 30 minute. For the generation of the operation maps, 1t , 
2t , 3t  and 4t  were simulated every 1 minute. The simulation results are presented as 
operating maps in form of 'mean size surface', in which the z value stands for simulated 
number-average mean size nL , and the x, y values stand for 2t  and 3t  for cooling first 
strategy, or 1t  and 4t  for antisolvent first strategy, respectively. The Scenarios S1 and S2, 
corresponding to the initial conditions discussed previously were also evaluated here. The 
results are shown in Figure 3.8 and Table 3.4. The simultaneous approach (point 0) 
according to which both cooling and antisolvent additions occur throughout the entire batch 
duration from 0 to 30 minute is used as base case for comparison. Points 1, 2, 3 and 4 are 
the optimum points for each strategy in the two initial conditions investigated (1–S1, 
cooling first; 2– S1, antisolvent first; 3– S2, cooling first; and 4– S2, antisolvent first). It 
can be found that for initial condition of S1, 1is larger than 2, indicating that cooling first 
strategy is better than antisolvent first strategy. However, for initial condition of S2, 3 is 
smaller than 4, indicating that cooling first strategy is worse than antisolvent first strategy. 




antisolvent concentration of the solubility surface in the initial points of S1 and S2 (Nagy 
et al., 2008b). In both scenarios the optimum points of the cooling first or antisolvent first 
strategies are better than the results obtained using the simultaneous cooling and 
antisolvent addition case. These results illustrate that significant improvement in product 
quality can be achieved by using the proposed systematic CCAC design approach. 
 
 
Figure 3.8. The mean size surfaces of cooling first and antisolvent first strategies for 
scenarios S1 and S2, respectively. Points (1)(2)(3)(4) are the corresponding optimum 
points. Point (0) is simultaneously cooling and adding antisolvent through 0 to 30 minutes, 
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Table 3.4. Comparison of the simultaneous case, optimal case of cooling first, and optimal 
case of antisolvent first through simulation. 



















1 [min]t   0 0 22 0 0 17 
2 [min]t   30 30 30 30 30 30 
3 [min]t   0 13 0 0 11 0 
4 [min]t   30 30 25 30 30 14 
[ ]nL m  319 529 334 384 452 524 
. .[ ]CV    0.376 0.283 0.319 0.300 0.272 0.219 
 
Both the full four parameter optimization and the simplified two parameter simulation 
based results are summarized in Table 3.5 for comparison.  
 
Table 3.5. Comparison of the suboptimal trajectories obtained by optimization and 
simulation. 
 S1 S2 
 Optimization Simulation Optimization Simulation 
1 [min]t   0.0 0 17.2 17 
2 [min]t   30.0 30 30.0 30 
3 [min]t   12.9 13 0.0 0 
4 [min]t   30.0 30 14.7 14 
[ ]nL m  529 529 527 524 





It can be seen that the differences between optimization and simulation results are 
negligible (and are within the discretization used in the simulation based approach). This 
indicates that the proposed simulation-based operating map can be used as a quick CCAC 
design approach. 
 
3.4.3 Experimental Validation of the CCAC Design Approach Using the Simulated 
Operating Map 
For the CCAC process of both cooling first and antisolvent first strategies corresponding 
to the initial condition S2, five cases were evaluated experimentally and were compared 
with the simulation results. These cases were selected based on the mean size maps (Figure 
3.8(c)(d)) developed using the simulations, as shown in Figure 3.9. The five cases 
correspond to the simultaneous cooling and antisolvent addition (case A), the optimal 
operating trajectories (corresponding to the largest mean sizes) for the cooling first and 
antisolvent first scenarios (cases B and D, respectively), as well as two additional non-
optimal points in the operating map corresponding to some smaller target mean sizes for 
both the cooling first and antisolvent first scenarios (cases C and E, respectively), which 
should produce the smallest crystals in both scenarios. The corresponding operating 
procedures were implemented experimentally. Both the nucleation time nuct (induction 
time) and the SWMCL obtained from the FBRM (as a qualitative estimate of the mean size 
used as the quality index) were used as criteria for comparison. The results are shown in 
Table 3.6. The experimental SWMCL was computed as the average of the measurements 






Figure 3.9. Comparison between experimental mean size (SWMCL) and simulated mean 
size ( nL ), when applying (a) cooling first strategy or (b) antisolvent first strategy 
corresponding to the initial condition of S2. Point A: simultaneous cooling and antisolvent; 
point B: optimal of cooling first; point C: non-optimal of cooling first; point D: optimal of 
antisolvent first; point E: non-optimum of antisolvent first. The color bar and 'sim' stand 
for simulated results. The number on the map and 'exp' stand for experimental results. The 
variation for experimental result is 2σ (95% confidence interval). 
 
According to Figure 3.10, the experimental times for the onset of nucleation (induction 
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nucleation kinetics from the literature (Lindenberg et al., 2009) is suitable for the 
experimental setup and conditions used in this work. 
 
Table 3.6. Comparison of simulated mean size and experimental SWMCL for the 





















1 [min]t   0 0 0 17 17 
2 [min]t   30 30 15 30 30 
3 [min]t   0 11 11 0 0 
4 [min]t   30 30 30 14 30 
*( ) [ ]nL sim m  
 384 452 358 524 272 
(exp)[ ]SWMCL m   151±6 164±16 125±6 170±16 137±8 
* 'sim' stands for simulated, 'exp' stands for experimental. 
 
In the case of cooling first strategy the induction times are relatively close to each other, 
nevertheless follow the same relative order both in simulation and experimentally. In the 
case of the antisolvent first strategy the induction time differences are larger, which is also 
in good agreement with the simulation results. The SWMCL at the end of the batches for 
both the cooling first and the antisolvent first strategies indicate that larger crystals are 
obtained in the cases of the optimal strategies (B and D). The selected cases for smaller 
desired mean particle size (C and E) result in significantly smaller SWMCL as expected. 




The experimental results are again in excellent agreement with the simulations in terms of 
the relative values. It might be noticed that in Figure 3.9, Figure 3.10 and Table 3.6, the 
absolute values of experimental SWMCL are smaller than the simulated mean sizes. This 
is a general trend in the case of FBRM data because the short chord lengths of crystals 
usually have higher probabilities to be measured by FBRM than longer chord lengths.  
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Figure 3.10. Comparison between (a) experimental mean size (SWMCL) of cooling first 
strategy and (b) antisolvent first strategy, (c) simulated mean size ( nL ) of cooling first 
strategy and (d) antisolvent first strategy, respectively. Case A: simultaneous cooling and 
antisolvent; case B: optimal of cooling first; case C: non-optimal of cooling first; case D: 
optimal of antisolvent first; case E: non-optimal of antisolvent first. 





















































Figure 3.11 and Figure 3.12 present the normalized cumulative chord length 
distributions and crystal images at the end of batch for each case, showing that the optimal 
cases do produce more large crystals, while the non-optimal cases selected with the goal 
of smaller sized crystal production create more fines. The experimental mean sizes 
indicated on Figure 3.9, are in very good agreement with the trend suggested by the mean 
size surface map. These result demonstrate that simulated mean size surface can be used 
as an efficient tool for the design of CCAC systems, reducing significantly the number of 




Figure 3.11. Normalized cumulative chord length distributions at the end of batch for each 
case of (a) cooling first strategy and (b) antisolvent first strategy. Case A: simultaneous 
cooling and antisolvent; case B: optimal of cooling first; case C: non-optimal of cooling 





Figure 3.12. Final crystals of case A (simultaneous cooling/ antisolvent), case B (optimal 
of cooling first), case C (non-optimal of cooling first), case D (optimal of antisolvent first), 
and case E (non-optimal of antisolvent first). All images have the same magnification. 
 
3.4.4 Full optimization of nonlinear trajectory based design of CCAC systems 
Based on the nonlinear model presented in the paper, the full optimization of the CCAC 
process was also evaluated. The initial condition, final condition, batch time and objective 
function are the same as section for the optimization problem of the simplified scenarios 
presented earlier (equations (3.15)–(3.19)). The computation of the optimal temperature 
trajectory and the antisolvent addition rate profile is formulated as a nonlinear optimization 
problem solved using a standard constrained nonlinear optimization approach based on 
SQP implemented in MATLAB. The batch time is discretized into N  ( 8N  ) intervals, 




considered as the optimization variables. The optimization problem can be written as 
follows: 
 . . . 1 0
( ), ( )
max { ( ) ( ) / ( )}
w
n m s n batch batch batch
T k F k
J L t t t     (3.20) 
subject to:  
model equations (3.5)–(3.14) 





    (3.22) 
 
w,min w w,maxF F (k) F    (3.23) 
    , ,(0) , ( ) , 0 ,liq liq initinitial fin ial liq liqa finallT T T N T m N mmm      (3.24) 
where minT  , maxT  , T,minR  , T,maxR  are the minimum and maximum temperatures and 
temperature ramp rates, respectively. 
w,minF , w,maxF  are the minimum and maximum 
antisolvent addition flow rates. initialT , finalT , ,liq initialm , ,liq finalm  
are the predetermined 
temperatures and masses of mother liquor for the initial and the final solutions. The first 
three constraints can ensure that the temperatures and antisolvent addition rates are in a 
proper operating range. The last equality constraints are used to fix both the initial and the 
final conditions of the solution at desired points. 
Multiple scenarios were evaluated here using the full optimization to obtain the optimal 
trajectories, which are shown in Figure 3.13. Similar to the previous section, scenarios with 
initial conditions corresponding to points A and B (scenarios S1opt and S2opt) were 





Figure 3.13. Optimal trajectories for S1opt, S2opt, and scenarios with other initial conditions. 
 
The optimal operating profiles, supersaturation ratio, 0 ( )t  
and concentration 
trajectories for S1opt and S2opt are shown in Figure 3.14 and Figure 3.15. For both S1opt and 
S2opt, it can be observed that the temperature decreases fast before primary nucleation 
occurs, and then remains almost constant during nucleating. The fast cooling at the 
beginning generates supersaturation and makes the solution reach fast the metastable limit 
for primary nucleation. The constant temperature stage afterwards ensures no more 
supersaturation is created during nucleation. This cooling pattern guarantees an early and 
well controlled nucleation, which allows the generation of an optimum amount of nuclei 
early in the process which then have longer time until the end of the batch to grow to larger 
sizes. These well controlled, early nucleation events can be observed from Figure 3.15(a). 
The results indicated a quick increase in supersaturation until the onset of nucleation after 
which the supersaturation declines and is maintained at a lower constant level to maintain 









































3.15(b), although the two scenarios have very different initial temperature and 
solvent/antisolvent ratio, they prefer almost the same concentration trajectory, which 
further demonstrates that the trajectories and the operating curves provided in Figure 3.13 
and Figure 3.14 are indeed optimal.  
 
Figure 3.14. Optimal operating curves for (a) S1opt and (b) S2opt. 
 
 
Figure 3.15. (a) Optimal supersaturation ratio and 0 ( )t  
for S1opt (solid line) and S2opt 
(dotted line); (b) optimal concentration trajectories for S1opt (solid line) and S2opt (dotted 
line). 











































































































































































































These results indicate that in principle the optimal operating trajectory for any 
crystallization processes is given by the optimal supersaturation profile, which is the actual 
driving force for both nucleation and growth. The optimization of the cooling and/or 
antisolvent addition will in principle provide only the means to achieve the optimal 
supersaturation trajectory within the existing operating constraints. Therefore, multiple 
combined cooling and antisolvent addition trajectories may lead to identical product quality 
since they may create similar supersaturation trajectory. 
An interesting observation from the full optimization results is that although the initial 
conditions given by points A and B have very different sensitivities for change of 
temperature and antisolvent concentration, the trajectories for both S1opt and S2opt have 
similar patterns, both characterized by cooling only induced nucleation, as well as 
combined cooling and antisolvent addition based growth. This phenomenon can be 
explained by the pronounced temperature effect on the nucleation and growth kinetics 
compared to the effect of supersaturation. The solubility surface based sensitivity analysis 
to determine whether a particular initial condition leads to antisolvent first or cooling first 
procedure only considers the effect of the supersaturation as the main driving force for 
achieving early primary nucleation. However, in the full optimization problem, the 
solubility surface based sensitivity no longer dominates the achievable results, because an 
early primary nucleation can be easily obtained by using a variable cooling rate or 
antisolvent addition rate (e.g. initial fast cooling followed by a slow cooling period), while 
the excessive nucleation can be avoided by decreasing the cooling (addition) rate 
immediately after nucleation occurred. When the cooling/addition rates are fixed this level 




found that is a result of the compromise between triggering fast the crystallization and 
avoiding excessive nucleation Since both of these kinetic phenomena also depend on the 
temperature in addition to the supersaturation in some cases this effect becomes more 
dominant. According to Table 3.1, the activation energy for the nucleation rate is three 
times higher than the activation energy for the growth rate. As a result, the nucleation rate 
will be much more sensitive to temperature change than the growth rate. In order to obtain 
a gentle well controlled primary nucleation, as well as to avoid nucleation during growth, 
a lower temperature is preferred, which can be achieved during the initial phase of the 
process, before the onset of primary nucleation. Thus, from this point of view, cooling is 
better than antisolvent to generate supersaturation for primary nucleation at the beginning 
of batch, to also bring the temperature to a level where nucleation rate can be better 
controlled relatively to the growth. However, to be able to achieve the early nucleation 
generation (for longer growth time) and the fine control of nucleation rate a varying cooling 
rate is necessary. As indicated by the optimal cooling profiles in Figure 3.14, the initial 
cooling rate is large followed by a period of practically no cooling. When the simplified 
scenario, with fixed cooling rate, is used for optimization this type of combined fast 
nucleation generation followed by gentle nucleation procedure cannot be achieved in both 
cases, hence the optimal operating procedures are different in those cases. This can be 
observed when both the full optimal and simplified trajectories corresponding to the initial 





Figure 3.16. Optimal trajectories (bold solid line) vs. suboptimal trajectories (thin dash line) 
for S1 and S2. 
 
When starting from a temperature sensitive region, both the optimal and the suboptimal 
trajectories perform cooling first, to ensure an early and gentle, well-controlled primary 
nucleation. However, when starting from antisolvent concentration sensitive region, the 
simplified trajectory cannot guarantee early primary nucleation and low temperature 
growth at the same time. The results provide an illustrative example how the proposed 
framework using the solubility surface and property map based simplified design of CCAC 
systems can be used for the rapid determination of simplified operating procedures for 
CCAC processes, but also illustrate that full optimization of nonlinear trajectory can yield 
better product properties (see Table 3.7) due to the finer control of nucleation that can be 
achieved by the time varying cooling and antisolvent addition rates. Because the 
differences between final crystal qualities achieved using the simplified CCAC design 














































process as soon as possible via controlled nucleation, therefore it is expected that in the 
case of seeded CCAC processes the differences between the approaches would be less 
significant. 
 
Table 3.7. Comparison of final product properties between suboptimal and optimal 
trajectories. 
 S1 S2 
 Suboptimal Optimal Suboptimal Optimal 
[ ]nL m  529 722 527 878 
. .[ ]CV    0.284 0.251 0.238 0.232 
 
3.5 Conclusions 
A novel model-based systematic analysis and design approach for unseeded combined 
cooling and antisolvent crystallization processes has been proposed and evaluated for the 
crystallization of aspirin in ethanol-water mixture. The cooling rate and antisolvent 
addition rate were kept constant to ensure that the operating curves are easy to implement 
in an industrial setup, whereas the cooling time and antisolvent feeding time were 
optimized to obtain large crystals. A strategy with simultaneous constant cooling and 
antisolvent addition, where cooling time and antisolvent feeding time were equal, was used 
as the base strategy for comparison. The simplified operating procedure allows the 
construction of operating maps for the combined cooling and antisolvent crystallization 
systems that can be used for better understanding of the conditions that govern these 




property. The advantage of the proposed methodology was presented through both 
simulations and experimental investigations, indicating that the base strategy could be 
further improved considerably. According to the proposed analysis, based on the sensitivity 
of the solubility surface, the simplified operating procedures should either belong to 
cooling first or antisolvent first strategy, depending on whether the initial solution locates 
at temperature sensitive region or antisolvent concentration sensitive region. The design 
based on the full optimization of nonlinear trajectory can provide further significant 
performance improvement due to the finer control of nucleation rate that can be achieved 
through the time-varying cooling and antisolvent addition rates. Although the proposed 
approach may have limitation in accuracy in the case of disturbances and model 
uncertainties due to the limitations of offline computed open-loop control trajectories, it 
provides an efficient and rapid experimental design method to significantly reduce the 




CHAPTER 4. COMBINED COOLING/ANTISOLVENT CRYSTALLIZATION IN 
MIXED SUSPENSION MIXED PRODUCT REMOVAL CASCADE 
CRYSTALLIZERS: STEADY-STATE AND STARTUP OPTIMIZATION8 
4.1 Introduction 
It is always important to optimize the steady-state operating conditions in the continuous 
crystallization process in order to obtain crystals of desired size, shape, etc. In addition, the 
startup problem is also crucial in the continuous crystallization, since the crystal properties 
are inconsistent before the continuous system can reach steady-state, and the time and the 
products are wasted during startup. Hence feasible methods to shorten the startup duration 
time and reduce the waste of material in the continuous crystallization systems are highly 
desirable. However, currently there are very few works reported to control and optimize 
the startup behavior of continuous crystallization system such as the MSMPR cascade (Su 
et al., 2015). 
In this work, both the steady-state and the startup behaviors of CCAC in multistage 
MSMPR cascade were evaluated and optimized through a model-based framework. The 
PBE model was used and solved using the method of moments. Firstly, the optimal steady-
state operating trajectories were obtained and compared with the optimal batch trajectory. 
                                                 
8 Reproduced with permission from Yang, Y., Nagy, Z.K., 2015. Ind. Eng. Chem. Res. 54, 5673–5682. 




Then different methods to shorten the startup duration and reduce the amount of waste were 
discussed. The methods include changing the initial solution compositions, applying 
dynamic antisolvent profiles, applying dynamic temperature profiles, and applying 
dynamic antisolvent/temperature combined profiles. Lastly, a concept of implementing 
model-free approach to optimize the startup behavior was proposed. Aspirin was used as 
the model compound in the case study, and ethanol and water were used as solvent and 
antisolvent, respectively. 
 
4.2 Mathematical Model 
In this work, a continuous N  stage MSMPR cascade system is modeled via population 
balance model. All the vessels are assumed to be well-mixed. The compositions of the 
outlet flow are identical to the slurry inside the crystallizer. The solvent/antisolvent mixing 
and the crystallization process do not affect the solution volume. The crystal breakage and 
agglomeration are assumed negligible. Then the PBE for the ith stage could be written as 
(Ramkrishna, 2000; Rawlings et al., 1993): 
 ( 1) ( )1
( , ) ( , )
( , ) ( , ) ,  1,2,...,i ii i i i iout i out i
V n L t V G n L t





   
 
  (4.1)
where ( , )in L t  is the volumetric number density (#/cm
3) at stage i , L  is the characteristic 
crystal size (cm), iG  is the growth rate (cm min
-1) at stage i , iV  (cm
3) is the solution 
volume at stage i , 
( )i
outF  is the outlet volumetric flow rate (cm







Equation (4.1) could be solved by the method of moments (Randolph, 1988). The jth 
moment of stage i  is represented by: 
  ( )
0
( , ) , 0,1, ,i j ij t L dL Ln t j

       (4.2) 
Take 
0
( 4.1) ,  1jx eqn dx j

 . To make the equations mathematically simple, assume the 
growth rate iG  is size-independent, and the solution volume iV  is constant. This 
assumption can be easily implemented in practice by using a level controller in the vessel. 
Then the following equation could be obtained: 
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Rearrange equation (4.3): 
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Similarly, the zeroth moment could be written as: 
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     (4.8) 
where iB  represents the nucleation rate (#/cm
3 min-1) at stage i . 
The mass balance equation for the solute at stage i was derived as: 
 
( )




i out i out i v c i
dc d
V F c F c k V
dt dt

      (4.9) 
where ic  is the solute concentration (g solute/g solvent mixture) at stage i . According to 













     (4.10) 
where vk  is the volume shape factor, c  is the crystal density. In this study, they are fixed 
at / 6 , 1.4 g/cm3, respectively (Lindengerg et al., 2009). 
The mass balance equation for the solvent ethanol at stage i  was derived as: 
 ( 1) ( )1
i ii
i out i out i
dv
V F v F v
dt

    (4.11) 







dt   

 
    (4.12) 
In this study, empirical equations (3.12), (3.13) and (3.14) were used to express 
nucleation rate, growth rate and relative supersaturation of aspirin in ethanol-water mixture. 
The solubility is calculated based on Table 3.2 and Figure 3.1 (Lindenberg et al., 2009; 




4.3 Results and Discussion 
4.3.1 Steady-State Optimization 
Figure 4.1 presents the schematic of using both cooling and antisolvent addition to 
generate supersaturation in multistage MSMPR cascade crystallizers. The feed solution is 
free of crystals so that the first stage is a nucleation stage while the rest stages are growth 
stages. Since there are two means to manipulate the supersaturation driving force, one 
could consider using temperature only, or antisolvent only, or both to control the 
supersaturation level for a certain stage. 
 
Figure 4.1. Schematic of performing CCAC in a multistage MSMPR cascade. 
 
The continuous MSMPR cascade system could finally reach steady-state and produce 
consistent products under certain fixed operating conditions. In this study, the optimal 
steady-state operating profiles of MSMPR cascade with N stages were obtained, using the 
maximum mean size as the objective. The temperature and the ethanol volume fraction of 
the feed solution are fixed as (
0 40 CT
  , 0 79.2%v   ) (79.2% in volume = 75% in mass), 




or Nth stage are fixed as ( 25 CNT
  , 45.8%Nv  ), (45.8% in volume = 40% in mass), 
respectively. The volumetric flow rate of the feed solution is a constant of 0 5 mL/minF  . 
The optimization problem can be written as: 
 ( ) ( ) ( ). . . 1 0
, ,
max { / },  1
i i i
N N N
n m s n
T F
J L i N

        (4.13) 
subject to: 
model equations (3.12)–(3.14), (4.7), (4.8), (4.10) and (4.12) 
 0 1 2 NT T T T       (4.14) 
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   (4.18) 
where iT  is the temperature ( C ) at stage i , iF  is the antisolvent addition rate (ml min
-1) 
at stage i . They are the optimization variables. NT  is the temperature ( °C ) of the final stage 
or N th stage. The inequality constraint (4.14) limits the cooling rate to be nonnegative. 
The equality constraints (4.15), (4.16) fix the feed solution temperature and the final 
temperature at stage N , while (4.17) fixes the final solvent composition at stage N . The 
last equality constraint (4.18) fixes the total residence time as 30 minutes. The objective 
function J  is some desired crystal properties at stage N. In this study the number-average 
mean size 




of variation ( nCV ). However, since there is often a tradeoff between crystal mean size and 
nCV , only single objective (crystal mean size) is included here in order to simplify the 
study. The optimization problem is solved using SQP algorithm. MATLAB function 
fmincon and default specifications are used. The above solution approach is used 
throughout the whole study. Since it is not practical to set up more than 3 stages in the 
cascade in the pharmaceutical industry, the scenarios when 1,  2,  3N   were computed. In 
addition, the batch system that has the same initial and final conditions as the feed solution 
and the N th stage of the cascade system, was compared as well. The batch time is 30 
minutes, which is exactly the same as the total residence time of the cascade system. The 
initial solutions at each stages are set to have the same ethanol volume fraction (79.2%) as 
the feed solution. The solute concentration of the initial solutions is at saturation of 25 °C , 
which equals 0.222 g /g solvent mixture. 
The optimal operating profiles were presented in Table 4.1. In a certain MSMPR system, 
it could be observed that the optimal residence time i  would increase as the stage number 
i  increases. This phenomenon does make sense, because in a typical crystallization 
operation, the time for growth should be much longer than nucleation in order to obtain 
large crystals. In a MSMPR cascade, the first stage generally acts as a nucleation stage 
whereas the rest of the stages are designed for growth. Also one could notice that the more 
stages are used in the cascade, the larger crystals with smaller size variations can be 
obtained. The batch system can achieve better products as compared to the cascade system, 
since it corresponds to the limiting optimal operating trajectory that could be achieved 




in equilibrium state whereas the continuous crystallization is operated in steady-state (Chen 
et al., 2011). 
 
Table 4.1. Optimal operating temperatures and antisolvent addition rates for cascade of 
1,  2,  3N  , and the batch system. 
N  1 stage 2 stages 3 stages batch 
o
1  [ C]T  
25 25 26.09 - 
o
2  [ C]T  
 25 25 - 
o
3  [ C]T  
  25 - 
-1
1  [mL min ]F  
3.65 1.05 0.00 - 
-1
2  [mL min ]F  
 2.60 1.60 - 
-1
3  [mL min ]F  
  2.05 - 
1  [min]  30 10.74 6.61 - 
2  [min]   19.26 11.37 - 
3  [min]    12.03 - 
1  [ml]V  259.5 64.98 33.05 - 
2  [ml]V   166.60 75.04 - 
3  [ml]V    104.06 - 
 [μm]nL  257.39 369.55 449.90 704.69 
 [-]nCV  1.000 0.790 0.683 0.250 
 
    The optimal trajectories of the four scenarios in Table 4.1 were compared in the 3D 
phase diagram, as shown in Figure 4.2. It can be noticed that the optimal cascade trajectory 
becomes more and more similar as the optimal batch trajectory when N increases, 




demonstrates that the batch trajectory can be regarded as a trajectory of MSMPR cascade 
of infinite number of stages for both the simple 2D crystallizations (i.e. cooling or 
antisolvent only crystallization), as well as for the 3D crystallization (i.e. CCAC). In other 
words, the knowledge of the optimal operating procedure for a CCAC process in batch 




Figure 4.2. Optimal trajectories of 1 stage (dotted line), 2 stages (dash-dotted line), 3 stages 
(dash line) cascade system and batch (solid line) system, shown in (a) 3D phase diagram 










































































For instance, if it is already known that cooling first is desired in CCAC in a batch 
system to produce large crystals, then it is very likely that cooling first should also be 
preferred in CCAC in MSMPR cascade system. This would be implemented by operating 
the first stage as a cooling crystallization and the second as antisolvent. If the batch 
operation requires simultaneous cooling and antisolvent addition, then most likely both 
stages of the MSMPR cascade would be operated using cooling as well as antisolvent 
addition. 
 
4.3.2 Startup Optimization 
The startup problem is very important in continuous manufacturing. The crystal 
properties are inconsistent before the continuous system can reach steady-state. As a result, 
the time and the products are wasted during startup. Therefore, the development of feasible 
methods to shorten the startup duration time and reduce the waste in the continuous 
crystallization systems can have high impact in continuous crystallization development and 
operation. 
 
4.3.2.1 Startup Optimization via Using Different Initial Solutions 
Typically, it is necessary to prepare some initial solutions for each stage before one turns 
on a continuous MSMPR cascade system. Theoretically the compositions of the initial 
solution at each stage should have some impact on the startup dynamic behavior, and 
maybe even the final steady-state product quality if multiplicity exists in the model. Hence 




simplify the analysis, it is assumed that the initial solutions for each stage in a cascade are 
the same when N  equals 2 or 3. Then the process is simulated via equations (3.12), (3.13), 
(3.14), (4.7), (4.8), (4.10) and (4.12), with different initial solvent volume fraction and 
solute concentration. The results are plotted in Figure 4.3, which indicates that the cascade 
system would always reach the same steady-state independently of the composition of the 
initial solutions in the vessels. Hence there is no multiplicity in the MSMPR cascade system 
in our case. In other words, the cascade system is robust to the variation of initial conditions. 
It also indicates that the results of the steady-state optimization are independent of how the 
initial solution compositions are chosen. However, the initial conditions can provide a way 
to shorten the startup duration time and reduce the waste by optimizing the compositions 
of the initial solutions. 
Then a 2 stage MSMPR cascade system is modeled here, since 2N   is the most often 
used configuration in the pharmaceutical industry considering both performance and the 
operation complexity. The solvent volume fraction and solute concentration of the initial 
solution at each stage are the optimization variables. The objective is the minimum t99 or 
t95, which can be defined as the time required for the system to reach a controlled state of 






min t i N     (4.19) 
subject to: 
model equations (3.12)–(3.14), (4.7), (4.8), (4.10) and (4.12) 







Figure 4.3. Final crystal mean size under various solvent volume fractions and solute 
concentrations of the initial solution, for cascade that has different number of stages: (a) 
























































































 1 1 10 ( , )c solubility T v    (4.21) 
 2 2 20 ( , )c solubility T v    (4.22) 
where 1v , 2v , 1c , 2c  are the ethanol volume fraction and solute concentration of stages 1 and 
2, respectively. The inequality constraints (4.20), (4.21), (4.22) can ensure that the 
optimization variables are in a proper range, and the solutions can be easily prepared in 
practice (no supersaturated initial solution is allowed). 
A constant operating profile obtained from Table 4.1, when 2N   is applied in this 
section. A scenario with the initial solution compositions discussed in section 4.3.1 is also 
used here as base case for comparison ( 79.2%v  , 0.222 g/g solvent mixturec   or 25 °C  
saturated solution). This solution is used as the initial solution for both stages. 
The optimization results are shown in Table 4.2 and Figure 4.4. The waste material 
produced in each scenario (amount of solute crystallized until the controlled state of 
operation is achieved) is also computed using the following equation: 
 
99
( ) ( )
99 3
0
 ( ) ( ) ( )
t
N N
v c outWaste t F t t dt      (4.23) 
The optimal case in Table 4.2 and Figure 4.4 indicates an improvement on the startup 
duration time 99t  as well as 99 ( )Waste t . However, the dynamic behavior of  ( )nL t  didn't 
change too much, in terms of the overshoots and the oscillations. Additionally, it can be 
noticed that in the optimal case, the initial concentration of the second stage is much smaller 
than the first stage. This is because the second stage, or the growth stage needs relatively 





Table 4.2. Comparisons between the compositions, 99t  and 99 ( )Waste t  of the base case 
and the optimal case, which uses 99min{ }t  as objective. 
 Base case 
99( )t  Optimal case 99( )t  
1  [g/g solvent mixture]c  0.222 0.201 
1  [-]v  79.2% 74.7% 
2  [g/g solvent mixture]c  0.222 0.026 
2  [-]v  79.2% 81.8% 
99  [min]t  143.1 106.7 
99 ( ) [g]Waste t  156.6 94.0 
 
 
Figure 4.4. Mean size  ( )nL t  and 99 ( )Waste t  (a) before and (b) after optimizing the 
compositions of the initial solutions when using 99 min t  as objective. 
 
In practice, instead of 1% deviation, sometimes 5% deviation is allowable. Hence, 





min t i N     (4.24) 
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where the constraints remain the same as in equations (4.20), (4.21) and (4.22). Then the 
waste that uses 95t  as criteria should be defined as: 
 
95
( ) ( )
95 3
0
 ( ) ( ) ( )
t
N N
v c outWaste t F t t dt      (4.25) 
    The optimization results using 95min{ }t  as objective are listed in Table 4.3 and Figure 
4.5. A similar improvement could be observed as using 99min{ }t  as objective. The 
difference is that, when using 95t  the improvement is more significant. This can be 
explained by the larger flexibility for optimization offered by the looser limits that define 
the controlled state of operation with 5% deviation as compared to the case with 1% 
deviation. 
 
Table 4.3. Comparisons between the compositions, 95t  and waste amount of the base case 
and the optimal case, which uses 95min{t   as objective.
 
 Base case 
95( )t  Optimal case 95( )t  
1  [g/g solvent mixture]c  0.222 0.207 
1  [-]v  79.2% 75.0% 
2  [g/g solvent mixture]c  0.222 0 
2  [-]v  79.2% 73.4% 
95  [min]t  100.1 59.9 






Figure 4.5. Mean size  ( )nL t  and 95 ( )Waste t  (a) before and (b) after optimizing the 
compositions of the initial solutions when using 95min{ }t  as objective. 
 
4.3.2.2 Startup Optimization via Applying Dynamic Operating Profiles 
Typically, the continuous MSMPR cascade system should be operated under some 
constant operating conditions in order to maintain steady-state and consistent product 
properties. However, during the startup it might be helpful to apply dynamic operating 
profiles to shorten the startup duration and reduce the waste. In the dynamic startup study 
a 2 stage MSMPR cascade system is investigated. The computation of the optimal dynamic 
temperature or/and antisolvent addition profiles are formulated as a nonlinear optimization 
problem solved using a SQP approach. Since the startup duration time is typically around 
100 minutes as shown before, a time period of 300 minutes is prepared for observation. 
The 300 minutes’ time period is then divided into 30 intervals, and the temperatures and 
the antisolvent addition rates at every discrete time are considered as the optimization 
variables. 
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4.3.2.2.1 Scenario 1: Dynamic Antisolvent Addition Profiles With Minimum t99 as 
Objective 
 If using 99t  as criteria and dynamic antisolvent flow rates with constant temperatures 




( ), ( )
,  0 30
F k F k
min t k

     (4.26) 
subject to: 
model equations (3.12)–(3.14), (4.7), (4.8), (4.10) and (4.12) 
 10 ( ) 10, 0,1,...,15F k k      (4.27) 
 20 ( ) 10, 0,1,...,15F k k      (4.28) 
 
1 1,( ) , 16,17,...,30ssF k F k     (4.29) 
 2 2,( ) , 16,17,...,30ssF k F k     (4.30) 
where 1( )F k , 2 ( )F k  are the antisolvent addition rates at the kth discrete time for stage 1 
and 2, respectively. 
1, ssF  , 2, ssF   are the steady-state operating values obtained from Table 
4.1. Inequality constraints (4.27), (4.28) limit the antisolvent addition rate in the proper 
operating range. Equality constraints (4.29), (4.30) force the antisolvent addition rates go 
back to the desired steady-state values, in order to ensure that the dynamic antisolvent 
profiles won't affect the product properties at the final steady-state. The initial solution 
compositions are the same as section 624.3.1, or the base case in section 4.3.2.1. All the 
other variables, such as the temperatures, the volumes, the feed solution flow rate and 
composition, remain the same as the steady-state values listed in Table 4.1. Thus, the base 




The optimal dynamic antisolvent profiles when using 99t  as criteria are plotted in Figure 
4.6. The antisolvent flow rates during startup are larger than the steady-state values, which 
makes sense because high supersaturation is necessary in order to make the system 
crystallize more quickly and strongly during startup than in the steady-state. The dynamic 
behavior of the mean size  ( )nL t  shows excellent trajectory, with almost no overshoot and 
oscillations anymore. The 99t  and 99 ( )Waste t  in Figure 4.6 are also reduced significantly, 
as compared to the base case (Figure 4.4(a)). Thus unlike changing the initial solution 
composition, the dynamic profiles can have much stronger influence on the dynamic 
behavior during startup. In addition, another scenario that uses 99 ( )min Waste t  
instead of  
99min{ }t  as objective is also computed. Finally, a similar optimal result as in scenario 1 is 
obtained. This is because overshoot and oscillations are eliminated, hence the less 99t  is, 
the less 99 ( )Waste t  would be. Thus it is reasonable to consider 99 min t  as the only 
objective. 
 
Figure 4.6. (a) Optimal dynamic antisolvent addition profiles, (b) corresponding mean size 
 ( )nL t  and 99 ( )Waste t  when using 99 min t  as objective. 
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4.3.2.2.2 Scenario 2: Dynamic Temperature Profiles With Minimum t99 as Objective 
Alternatively, dynamic temperature profiles could be applied instead of dynamic 





( ), ( )
,  0 30
T k T k
min t k

     (4.31) 
subject to: 
 
model equations (3.12)–(3.14), (4.7), (4.8), (4.10) and (4.12) 
 115 ( ) 40, 0,1,...,15T k k      (4.32) 
 215 ( ) 40, 0,1,...,15T k k      (4.33) 
 
1 1,( ) , 0,16,17,...,30ssT k T k     (4.34) 
 
2 2,( ) , 0,16,17,...,30ssT k T k     (4.35) 
where 1( )T k , 2 ( )T k  are the temperatures at the kth discrete time for stage 1 and 2, 
respectively. Equations (4.34) and (4.35) contain more equality constraints than (4.29) and 
(4.30). In (4.34) and (4.35), the equality constraints include 1 1,(0) ssT T   and 2 2,(0) ssT T  , 
whereas in (4.29) and (4.30) of scenario 1, 1 1,(0) ssF F   and 1 1,(0) ssF F   are not listed as 
constraints. This is because in practice, the antisolvent flow rates could achieve a large step 
change within a negligible time period, whereas the temperatures couldn't.  
The optimization results of scenario 2 are plotted in Figure 4.7, in which some similar 
phenomena could be observed as scenario 1. The temperatures during startup are lower 
than the steady-state values, resulting in relatively higher supersaturation and quicker 




the performance in scenario 1, and both of these are much better than the base case (Figure 
4.4(a)). 
 
Figure 4.7. (a) Optimal dynamic temperature profiles, (b) corresponding mean size  ( )nL t  
and 99 ( )Waste t  when using 99min{ }t  as objective. 
 
4.3.2.2.3 Scenario 3: Dynamic Combined Profiles With Minimum t99 as Objective 
In this case startup optimization is considered using dynamic antisolvent profiles and 
dynamic temperature profiles simultaneously. The optimization problem using the 
dynamic combined profiles can be written as following: 
 
1 2 1 2
99
( ), ( ), ( ), ( )
,  0 30
F k F k T k T k
min t k
  
     (4.36) 
subject to: 
model equations (3.12)–(3.14), (4.7), (4.8), (4.10) and (4.12) 
constraints (4.27)–(4.30), (4.32)–(4.35) 
    The optimization results of scenario 3 are shown in Figure 4.8. The performance and 
conclusions are generally similar to the previous two scenarios.  
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Figure 4.8. (a) Optimal dynamic antisolvent addition profiles, (b) optimal dynamic 
temperature profiles, (c) corresponding mean size  ( )nL t  and 99 ( )Waste t  when using 
99min{ }t  as objective. 
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The dynamic antisolvent flow rates here have much stronger effect on decreasing startup 
duration than the dynamic temperatures. This is because the antisolvent flow rates can also 
affect the residence time whereas the temperatures cannot. Considering the dynamic 
operation complexity and cost, thus a practical way to implement this design is to apply 
dynamic antisolvent flow rates only, while keeping the temperature profiles constant, as in 
scenario 1. 
 
4.3.2.2.4 Scenario 4: Dynamic Combined Profiles With Minimum t95 as Objective 
As shown in the previous section the antisolvent flow rates have stronger impact on the 
system than the operating temperatures. Thus a scenario using dynamic antisolvent profiles 
only and 95min{ }t  as objective was considered. The only difference between scenario 1 
and scenario 4 is the objective function. All the other optimization formulations are the 
same as in scenario 1.  
 
Figure 4.9. (a) Optimal dynamic antisolvent addition profiles, (b) corresponding mean size 
 ( )nL t  and 95 ( )Waste t  when using 95min{ }t  as objective. 
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The optimal results are plotted in Figure 4.9, which indicates a great improvement on 
startup duration time and waste when comparing with the base case (Figure 4.5(a)). But 
since 5% deviation still allows room for overshoot and oscillation, they can hardly be 
eliminated when setting 95min{ }t as objective. 
Finally, the performance of all scenarios and base cases are summarized in Table 4.4 
for comparison, from which at least about 50% improvement can be observed when using 
dynamic operating profiles during startup. 
 
Table 4.4. Comparisons between the performance of all scenarios and base cases. 
 
99  [ ]t min  99 ( ) [g]Waste t  95  [min]t  95 ( ) [g]Waste t  
Without dynamic profiles (base case) 143.1 156.6 100.1 97.2 
Dynamic antisolvent profiles (scenario 1, 
4) 
83.0 80.4 27.5 6.6 
Dynamic temperature profiles (scenario 2) 83.1 81.0 -- -- 
Dynamic combined profiles (scenario 3) 80.1 77.4 -- -- 
 
4.3.2.3 Startup Optimization via Model-Free Approach 
Typically, the methods to control crystallization can be distinguished as model-based 
approach and model-free (direct design) approach (Nagy and Braatz, 2012; Nagy et al., 
2013). In the previous discussion a model-based approach is used, which is an offline 
control method and it may not be robust to the outside disturbances as well as the model 
uncertainties. Thus a model-free, or direct design approach can also be considered. In the 
model-free approach of the batch system, typically two methods are used via closed-loop 




the slurry in a certain range (Abu Bakar et al., 2009; Saleemi et al., 2012a, 2012b). The 
other method is the SSC, which uses ATR spectroscopy to measure the solute concentration 
and controls the supersaturation level to follow a certain trajectory (Saleemi et al., 2012b; 
Woo et al., 2009). These two methods have been demonstrated to be very efficient in the 
control of batch operation. Two similar methodologies can be proposed in the MSMPR 
cascade system to improve the startup behavior. By using FBRM as the sensor in the 
closed-loop, the crystal counts are measured in real time. When the counts are lower than 
the desired steady-state value, the control loop could result in a higher antisolvent addition 
rate or lower temperature to increase the supersaturation level, and vice versa. By using 
ATR spectroscopy, a higher antisolvent addition rate or lower temperature should be 
actuated when the supersaturation is measured lower than the desired steady-state value, 
and vice versa. These two model-free approaches are promising in the automatic control of 




A continuous MSMPR cascade system of different number of stages has been modeled 
and utilized to optimize both the steady-state and startup behaviors when both cooling and 
antisolvent addition are applied as the crystallization driving forces. Aspirin-ethanol-water 
is used as the model system in the study. In the steady-state optimization, the optimal 
steady-state operating profiles have been obtained. In addition, the optimal trajectories for 
both MSMPR cascade and batch systems have been plotted together in 3D phase diagram, 




infinite number of stages has been observed in 3D crystallization (i.e. CCAC) for the first 
time. Besides, different methods to shorten the startup duration time and reduce the waste 
have been discussed and proved to be feasible. These methods include changing the initial 
solution compositions, applying dynamic antisolvent profiles, applying dynamic 
temperature profiles, and applying dynamic antisolvent/temperature combined profiles. 
The most efficient and practical way to minimize startup duration and waste is to use 
dynamic antisolvent profiles only during startup.  It was shown that this approach could 
reduce the startup duration and the amount of waste with approximately 50% while having 
no impact on the final steady-state product properties. Finally, a model-free approach to 





CHAPTER 5. ADVANCED CONTROL APPROACHES FOR COMBINED 
COOLING/ANTISOLVENT CRYSTALLIZATION IN CONTINUOUS MIXED 
SUSPENSION MIXED PRODUCT REMOVAL CASCADE CRYSTALLIZERS9 
5.1 Introduction 
While model-based optimization, design and experimental investigation of continuous 
single stage and multistage MSMPR systems is becoming more common in the literature, 
currently there are no published papers working on model-based advanced control 
approaches for CCAC in MSMPR cascade crystallizers, with both crystal size and yield 
controlled at the same time. To achieve this goal, this chapter systematically studied the 
feasibility of two different control schemes: decentralized PID control and nonlinear model 
predictive control (NMPC). For decentralized PID control approach, local linearization 
method and relative gain array (RGA) analysis were used to examine its feasibility. 
Whereas for NMPC approach, its performance was evaluated under both servo control and 
regulatory control scenarios. In this work, not only nucleation and growth kinetics, but also 
controlled dissolution kinetics were considered. In the case study, aspirin (acetylsalicylic 
acid), ethanol and water were used as model compound, solvent and antisolvent, 
respectively.
                                                 
9 Reproduced with permission from Yang, Y., Nagy, Z.K., 2015. Chem. Eng. Sci. 127, 362–373. Copyright 




The schematic representation for a closed-loop hierarchical NMPC implementation 
structure in continuous two stage MSMPR cascade crystallizer is presented in Figure 5.1. 
In principle, PAT tools like FBRM and UV/Vis spectroscopy can be used for online 
measurements of CSD and solute concentration, from which mean crystal size and yield 
can be inferred in real time. As a result, the process model can be updated during the 
process using those measurements via closed-loop optimal control. Sensor noise and error 
are not considered in this work. In addition, in practice typically low level flow rate and 
temperature controllers would be used in a hierarchical control structure with the NMPC, 
as shown in Figure 5.1. In this work, in order to simplify the simulation study, antisolvent 










Figure 5.1. Schematic representation of a hierarchical NMPC implementation structure.  





5.2 Mathematical Model 
In this work, a continuous a two stage MSMPR cascade crystallizer is modeled using 
PBM. Both the temperature and antisolvent addition rate can be manipulated at both stages, 
in order to control supersaturation levels and residence times (Figure 5.2). The crystal mean 
size and yield of the second stage are the two controlled variables. The following 
assumptions are used in this work: (1) vessel is ideally well-mixed (2) the outlet flow 
contains exactly the same compositions as inside the vessel (3) only nucleation, growth 
and dissolution are considered, whereas breakage or agglomeration are negligible (4) 
mixture of aspirin, ethanol and water is ideal solution. 
The process is described using the same mathematical model as in chapter 4. In addition, 
in this chapter the crystal dissolution kinetic is also considered: 
 3*2
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  (5.2) 
where S  is the supersaturation ratio [-], 
*c  is the equilibrium solubility [g/ml], T  is 
temperature [oC]. GD  and BD  are dissolution rates. When 1S  , the negative values of 
nucleation rate and growth rate are used to approximate dissolution rates (Qamar et al., 
2010; Nagy et al., 2011). 1Gk , 2Gk , 3Gk , 1Bk , 2Bk , 3Bk  are empirical parameters from 
literature (Lindenberg et al., 2009). 
Assume nL  and Y  are number based mean crystal size [ m ] and yield [-] of the second 














    (5.4) 
In this study, heat transfer and model mismatch is not considered. 
Antisolvent F1 Antisolvent F2Feed solution
Temperature T1 Temperature T2
Crystal mean size Ln
Yield Y  
Figure 5.2. Schematic representation of the continuous CCAC process in a two stage 
MSMPR cascade crystallizer. 
 
5.3 Results and Discussion 
5.3.1 Attainable region of crystal size and yield 
According to Figure 5.2, the proposed control structure can be considered as a multi-
input multi-output (MIMO) system, as shown in Figure 5.3. Since in this process more 
potential manipulating inputs exist than desired controlled variables, it is interesting to 
evaluate different control architectures. Five control methods are investigated based on the 




The basic operating scenario was defined as: 1F , 2F , 1T , 2T  equal 1.05 ml/min, 2.60 
ml/min, 25 oC, 25 oC, respectively. It was found that crystal mean size nL  and yield Y  
would reach constant values of 369 µm and 0.685 after the system reaching steady-state, 
by simulating the process based on equations (3.12)–(3.14), (4.7), (4.8), (4.10), (4.12), and 
(5.1)–(5.4). 
 
Figure 5.3. Schematic representation of investigated multi-input multi-output system. 
 
Table 5.1. Five possible different control approaches for two-stage MSMPR cascade 
crystallization systems. 




1F , 1T  
Growth control 2F , 2T  
Antisolvent control 1F , 2F  
Temperature control 1T , 2T  
Global control 1F , 2F , 1T , 2T  
 
For the manipulated input variables, the following operating limits were used: 
 1 20 ,  10 mL/minF F    (5.5) 
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The attainable regions of crystal size and yield of the proposed five control methods can 
be obtained by simulating the process considering model equations and operating limits. 
Since the process is highly nonlinear and dissolution is also considered, it is possible that 
the maximum and minimum crystal sizes corresponding to a certain yield may not 
guarantee that the crystal sizes in between are also achievable. Therefore, an exhaustive 
search method is used based on a Monte Carlo type simulation study. The process is 
simulated, and the crystal size and yield are recorded repeatedly, with each variable taking 
a value within the operating limits and changing with a small step in the next simulation. 
The hierarchical for loops were implemented in MATLAB. Finally, the boundary of all 
recorded crystal sizes and yields were plotted, as presented in Figure 5.4. It should be 
acknowledged that the attainable regions (except global control) depend on the values of 
the unchanged variables, however the following phenomena are always observed. Due to 
the largest degree of freedom, the non-square global control method has the largest 
attainable region. Antisolvent and temperature control methods also have relatively large 
attainable regions, because they can manipulate supersaturation at both stages. Since 
nucleation and growth control methods can only well control one of the two stages, they 
have relatively small attainable regions. In addition, the Pareto front of crystal size and 
yield is clear in global control method, indicating that generally there is a compromise 
between crystal size and yield. Within the operating limits, large crystal size and high yield 
are difficult to achieve at the same time. Different control approaches enable to operate at 
different combinations of size and yield, and unless the global control is used changing the 




architecture. These attainable regions are used in the development of advanced control 
frameworks discussed later.  
 
Figure 5.4. Attainable regions of crystal size and yield in the case of the proposed five 
control methods. Operating points 1–7 were used in decentralized PID control analysis. 
Operating points 1, 8, 9 were used in NMPC analysis. 
 
5.3.2 Analysis of System Dynamics 
Before proposing the control approach, it is beneficial to investigate the basic dynamic 
features of the studied MIMO system (e.g. whether the system is linear or nonlinear, or 
how inputs and outputs interact). In this work, the response of each output variable is 
analyzed when step changes of each input variable are performed. As shown in Figure 5.5, 
starting from basic operating scenario at 0 minute, 1F , 2F , 1T , 2T  are increased by a step 





































change of 0.5 ml/min or 3 oC at 100 and 400 minutes, respectively. According to the 
response curves for crystal size and yield, it is clear that there is strong interaction among 
the four inputs and the two outputs. In addition, inverse responses and oscillations are 
present, and the system is nonlinear and complex. For example, the crystal mean size will 
finally increase if 2T  is increased by a small step, however it will decrease if 2T  is increased 
by a large step (Figure 5.5(d)). The size increase is caused by the controlled dissolution 
and fines removal of mild heating at the second stage, whereas large particles are dissolved 
and crystal mean size is reduced if the second stage is heated too much. 
 
Figure 5.5. Response of crystal mean size and yield with respect to step change in (a) 
antisolvent addition rate at stage 1 ( 1F ), (b) antisolvent addition rate at stage 2 ( 2F ), (c) 
temperature at stage 1 ( 1T ), and (d) temperature at stage 2 ( 2T ). 


















































































































































5.3.3 Feasibility of Decentralized Proportional-Integral-Derivative (PID) Control 
Decentralized PID control is a general control approach for MIMO control systems. It 
is relatively easy to implement since only standard PID controllers are required. Using 
decentralized control the interacting MIMO system is controlled using two single-input 
single-output systems. The design of the decentralized control requires pairing each 
controlled variable with manipulated variable. The feasibility of this approach was 
evaluated using local linearization method and relative gain array (RGA) analysis. Global 
control method is not discussed here since RGA analysis requires equal number of inputs 
and outputs.  
 
Table 5.2. Selected operating points for local linearization and RGA analysis. 




nL [µm] Y [-] 
Nucleation control 
1 1.05 2.60 25.0 25.0 369 0.685 
2 3.00 2.60 15.0 25.0 214 0.740 
Growth control 
1 1.05 2.60 25.0 25.0 369 0.685 
3 1.05 2.50 25.0 20.0 204 0.761 
Antisolvent control 
1 1.05 2.60 25.0 25.0 369 0.685 
4 3.00 3.00 25.0 25.0 205 0.741 
5 0.50 0.50 25.0 25.0 417 0.498 
Temperature control 
1 1.05 2.60 25.0 25.0 369 0.685 
6 1.05 2.60 15.0 15.0 217 0.836 
7 1.05 2.60 30.0 35.0 487 0.479 
 
For the proposed other four control methods, firstly two or three operating points from 




condition and exact position of these points are indicated in Table 5.2 and Figure 5.4. It 
should be noticed that point 1 is the basic operating scenario. 
Assume the standard mathematical representation of a linear time invariant (LTI) state-
space model is: 
 
dx
A x B u
dt
      (5.7) 
 y C x D u      (5.8) 
where x  is the model state vector, u  is input and y  is output. In this work, the process 
model was linearized at different operating points mentioned in Table 5.2 using the 
linearization toolbox in Simulink, in which matrices A , B , C , D  can be obtained. These 
matrices are then used to calculate the RGAs at those operating points using the following 
equation: 
 
1 1 1( ) (( ) )TRGA CA B D CA B D          (5.9) 
where A , B , C , D  are matrices from LTI state-space model (5.7), (5.8). For convenience, 
we write 1F , 2F , 1T , 2T , nL , Y  as 1u , 2u , 3u , 4u , 1y , 2y , respectively. Since there are only 




























RGA can be used as a tool for control pairing. The pairing which has positive 
ij  closest 
to one is the most desired. The final RGAs and pairings obtained at those operating points 
are summarized in Table 5.3. 
 
Table 5.3. RGAs and input-output pairings for selected operating points of the four 
proposed control methods. 


















































































































































































The results indicate that for a certain control method, the feasible pairing between inputs 




control pairing is necessary when the operating point is changed. Thus decentralized PID 
control approach is not convenient to be implemented when a relatively large operating 
region is required, since suitable control would require change in input-output topology 
and use a variable control structure. This is caused by the significant interactions among 
inputs and outputs and strong nonlinearity of the process. These results demonstrate that 
conventional control of a cascade MSMPR may not be practically feasible in none of the 
configurations when changing operating conditions or product quality specifications are 
required and the use of more advanced control approaches such as NMPC may be required. 
 
5.3.4 Feasibility of Nonlinear Model Predictive Control (NMPC) 
5.3.4.1 NMPC Problem Formulation 
Compared to decentralized PID control, NMPC is a more advanced control approach 
since it can handle complex and highly nonlinear systems. NMPC approach uses the 
current measurements and nonlinear model to calculate the predicted output variables in a 
future time period named as prediction horizon. The future input variables in the prediction 
horizon are optimized to hold the output variables close to the set-point. Typically, only 
the first point of each optimal input variable is implemented. This optimization is then 
repeated when the next measurement is available. In this work, sampling time ( ) was 
chosen as 2 minutes. Prediction horizon ( P ) or number of prediction intervals was chosen 
as 25. Control horizon ( M ) or number of control moves was chosen as 5. In this work, 
open-loop optimal control solution approach was used, and model mismatch was not 
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subject to: 
model equations (3.12)–(3.14), (4.7), (4.8), (4.10), (4.12), and (5.1)–(5.4), 
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 ( ) ( ),   ( 1) ,..., ,   1,2,3,4i i k k k pu t u t M t t M t T i          (5.18) 
 1 20 ( ), ( ) 10,   , ,...,k k k pu t u t k t t t T        (5.19) 
 3 410 ( ), ( ) 40,   , ,...,k k k pu t u t k t t t T        (5.20) 
 ( ) ( ) ,   , ,..., ,   3,4i i k k k pu t u t k t t t T i               (5.21) 
 1( ) ( ) ,   3,4i k i ku t u t i        (5.22) 
where kt  is the first time point of the k th optimization, pT  is the time length of prediction 




respectively. Equations (5.13), (5.14) are cumulative errors of crystal size and yield 
compared to their corresponding set-points. Equations (5.15), (5.16), (5.17) are penalty 
term for the inputs, which can help avoid sharp change in inputs and promote smooth input 
responses and closed loop stability, u  is a matrix that contains variations of each input, 
Q  is a diagonal weighting matrix, as shown in equation (5.17) for the global control 
method. In the case of the other four control methods, if iu  is not used as manipulated 
variable, then iiQ  becomes zero.  To reduce the number of optimization variables while 
maintaining long enough prediction horizon for stability, inputs after the control horizon 
(M) were set equal to the last values of inputs in the control horizon, as shown in equation 
(5.18). Equations (5.19), (5.20) are operating limits for the inputs. Equations (5.21) and 
(5.22) are the temperature rate limits that are set as ±1 oC/min. w  is the weight for penalty 
term, which is chosen as 0.05. As shown in the objective function (5.12), crystal size and 
yield were set of equal weights. SQP technique was used to solve the optimization problem. 
 
5.3.4.2 Servo Control 
A servo control scenario was designed to evaluate the feasibility of NMPC using the 
five proposed control methods. As presented in Table 5.4, three set-points (points 1, 8 and 
9) were selected from the attainable region (Figure 5.4) in order to evaluate NMPC 
performance when fast change-over among these set-points are required. The operating 
points 1, 8 and 9 correspond to three typical desired product properties: medium size and 
medium yield, high yield and small size, and large size with low yield. It should be noticed 




point 9 is outside of the attainable regions of nucleation and growth control methods (Table 
5.4). Points 1, 8 and 9 have similar positions as the operating points selected in the analysis 
of decentralized PID control, making the evaluations of decentralized PID control and 
NMPC comparable. The results indicate that the NMPC performs well even in the case 
when decentralized PID control would require change in the control architecture. During 
time 0 to 50 minutes, the system was assumed to work at steady-state with operating point 
1 used as set-point. Then the set-point was changed to point 8, point 1, point 9 at 50 minutes, 
200 minutes, 350 minutes, respectively, as indicated in Table 5.4. 
 
Table 5.4. Selected set-points to evaluate NMPC feasibility. 
Time [min] Set-point 
Point Belonged attainable region Mean size [µm] Yield [-] 
0 - 50 1 Nucleation control, Growth control, 
Antisolvent control, Temperature control, 
Global control 
369 0.685 
50 - 200 8 Nucleation control, Growth control, 
Antisolvent control, Temperature control, 
Global control 
200 0.720 
200 - 350 1 Nucleation control, Growth control, 
Antisolvent control, Temperature control, 
Global control 
369 0.685 




The NMPC performance of the antisolvent control method is used as an example for 
detailed analysis. The controlled variables, manipulated variables, concentration and 





Figure 5.6. NMPC performance of the antisolvent control method: (a) crystal size, yield 
and coefficient of variation (C.V.) of the CSD (red dotted lines are set-points); (b) 
antisolvent addition rates at stage 1 and 2; (c) concentration and supersaturation ratio; and 
(d) CPU time. 
 
For the antisolvent control method, the NMPC scheme responds fast to the set-point 
change among points 1, 8, and 9, and finally maintained the system at steady-state at the 
new set-points (Figure 5.6(a)). Although coefficient of variation is not a controlled variable, 
it is monitored here in order to guarantee that after the crystal mean size reaches a steady-
state value, the width of size distribution is also in steady-state. Additionally, the 























































































































































































manipulated input responses are generally smooth (Figure 5.6(b)). Figure 5.6(c) indicates 
that high supersaturation level is desired at the first stage when high yield and small crystal 
size are the control objectives, whereas low supersaturation levels at both stages are 
preferred when large crystal size and low yield are desired. In general, for most 
optimizations the CPU time was less than 2 minutes, which was smaller than the sampling 
time (Figure 5.6(d)). This indicates that the proposed framework is promising for practical 
implementation. However, it has to be mentioned that the solution approach for the NMPC 
optimization was based on simple sequential solution technique implemented in MATLAB. 
The computational time can be reduced significantly using more efficient optimization (e.g. 
multiple shooting) and/or other software implementation such as OptCon (Mesbah et al., 
2011, 2012; Nagy et al., 2007; Simon et al., 2009a). 
The NMPC performances of the other four control methods are shown in Figure 5.7 and 
Figure 5.8. Generally, the NMPC works well for the operating points that are within the 
attainable region of a particular control approach. Since operating point 9 is outside of the 
attainable region of the growth and nucleation control approaches these are unable to bring 
the system to this operating point. The extra degrees of freedom in the case of global control 
method provides faster response however requires longer CPU time due to larger number 
of optimization variables. The feasibilities of NMPC of all five proposed methods are 
summarized in Table 5.5. According to Table 5.4 and Table 5.5, the necessary condition 
for a certain control method and NMPC scheme to be feasible is that the set-point must be 
within the attainable region of that control approach. The NMPC optimization problem will 




region of crystal size and yield is important for choosing and designing a certain control 
approach. 
 
Figure 5.7. NMPC implementations: (a) controlled variables of nucleation control; (b) 
manipulated variables of nucleation control; (c) controlled variables of growth control; (d) 
manipulated variables of growth control (red dotted lines are set-points). C.V. is coefficient 
of variation of the CSD. 
















































































































Figure 5.8. NMPC implementations: (a) controlled variables of temperature control; (b) 
manipulated variables of temperature control; (c) controlled variables of global control; (d) 
manipulated variables of global control (red dotted lines are set-points). C.V. is coefficient 
of variation of the CSD. 
 
5.3.4.3 Regulatory Control 
Disturbances are unavoidable in actual processes. Therefore, it is important to know 
how disturbances can influence the attainable regions of crystal size and yield. For example, 
when feed flow rate changes from 5 ml/min to 6 ml/min, it is found that the basic operating 
set-point (point 1) is no longer within the attainable region of nucleation, antisolvent and 



































































































































temperature control methods, as shown in Figure 5.9. This is because the attainable regions 
shift due to this disturbance. As discussed in previous section, the necessary and sufficient 
condition for a certain control method and NMPC scheme to be feasible is that the set-point 
must be within the attainable region of that control approach. Therefore, in principal these 
three methods can no longer produce on-spec products if such a disturbance exists. Since 
the attainable region of global control method is the largest, and also it shifts the least, the 
global control method should be much more robust than the other four methods in terms of 
disturbance rejection. 
 
Table 5.5. NMPC performance using the five proposed control methods. 
Time [min] Set-point 
NMPC is feasible (Y) or not (N) 
Control method 
Antisolvent Temperature Nucleation Growth Global 
0 - 50 1 Y Y Y Y Y 
50 - 200 8 Y Y Y Y Y 
200 - 350 1 Y Y Y Y Y 
350 - 500 9 Y Y N N Y 
 
Thus regulatory control was considered in this section to evaluate the disturbance 
rejection of the NMPC in the case of the global control method. Two scenarios were 
investigated for disturbance rejection, one with disturbance in the feed solution flow rate 
0F  and another in the concentration 0c , respectively (Table 5.6). Step disturbances of 




set-point was maintained at operating point 1 ( 369 ,  0.685nL m Y  ) all the time for 
both scenarios. The disturbance profile, controlled variables and manipulated variables for 
scenario 1 and 2 are presented in Figure 5.10.  
 
Figure 5.9. Attainable region of crystal size and yield when feed flow rate increases from 
5ml/min to 6ml/min. Operating point 1 is the basic operating set-point. 
 
Table 5.6. Two scenarios for disturbance rejection evaluation. F0, c0 are feed solution flow 
rate and solute concentration. 
Time [min] 
Scenario 1 Scenario 2 
0F  [mL/min] 0c  [g/mL] 0F  [mL/min] 0c  [g/mL] 
0 - 50 5.0 
0.40 5.0 
0.40 
50 - 200 6.0 0.44 
200 - 350 5.0 0.40 
350 - 500 4.0 0.36 






























Figure 5.10. Performance of the global control NMPC for disturbance rejection: (a) 
scenario 1, disturbance profile in feed flow rate (F0), crystal size, yield, and coefficient of 
variation (C.V.) of CSD (red dotted lines are set-points); (b) scenario 1, manipulated 
variables: F1, F2, T1, T2 are antisolvent addition rates and temperatures at stages 1 and 2; 
(c) scenario 2, disturbance profile in feed concentration (c0), crystal size, yield, and 
coefficient of variation (C.V.) of the CSD (red dotted lines are set-points); (d) scenario 2 
manipulated variables. 
 
It is clear that the crystal size and yield can be well controlled at around the desired set-
point, even though large disturbances from feed solution are present. The coefficient of 











































































































































































variation (or width of size distribution) can also be kept almost constant under the 
simulated large disturbance. Thus the proposed NMPC approach is robust in terms of 




A continuous two stage MSMPR cascade crystallizer was modeled in this work using 
population balance model, with both cooling and antisolvent addition applied to generate 
supersaturation. A MIMO control system was investigated, with crystal size and yield 
targeted as controlled variables, and antisolvent addition rates and temperatures at both 
stages used as manipulated variables. In addition, based on different selections of 
manipulated variables, five control methods (nucleation control, growth control, 
antisolvent control, temperature control, and global control) were discussed. The attainable 
regions of crystal size and yield of the proposed five control methods were obtained. The 
feasibility of two advanced control approaches, decentralized PID control and NMPC were 
evaluated. Decentralized PID control was proved to require change of control structure 
when a relatively large operating region is essential based on local linearization method 
and relative gain array (RGA) analysis, indicating that this process requires more advanced 
control approaches, such as NMPC, for smooth operation. It was found that the necessary 
condition for NMPC to be feasible is that the set-point must be within the corresponding 
attainable region of that particular control method. In general, when this condition is met, 
NMPC scheme may be able to show good control performance for fast target product 




rejection. It is also shown that the non-square global control approach with four 
manipulated inputs (temperatures and flows in both stages) provides faster closed loop 
response and the largest attainable region. However, it should be noted that the practical 
performance of the NMPC highly depends on the accuracy of the model used in the 
controller. Another limitation of NMPC is related to sensor noise and error, which are not 
considered in this study either. But they can be quantified using experimental data in future 
works. These uncertainties would lead to variations in the boundaries of the attainable 
regions for control and could be incorporated in formulating the robust NMPC counterpart 




CHAPTER 6. INTEGRATED UPSTREAM AND DOWNSTREAM APPLICATION 
OF WET MILLING WITH CONTINUOUS MIXED SUSPENSION MIXED 
PRODUCT REMOVAL CRYSTALLIZATION10 
6.1 Introduction 
The application of wet mill in continuous crystallization processes is rarely reported in 
literature. In this work, it is used not only as a downstream unit operation for size reduction 
but also as an upstream continuous high shear nucleator for the first time. We proposed a 
novel concept of continuous wet mill seed generation (WMSG) whereby wet milling is 
used as an upstream unit operation before crystallization as a continuous seed generation 
process via high shear primary nucleation to decouple the mechanism of nucleation from 
growth controlled in the continuous crystallization unit. The integrated processes that use 
wet milling downstream as size reduction or upstream as seed generator are compared with 
the standard continuous MSMPR operation without wet milling using paracetamol 
(acetaminophen) in ethanol solvent as the model compound in a cooling crystallization 
process. The effect of wet milling on the startup duration is also studied.
                                                 
10 Reproduced with permission from Yang, Y., Song, L., Gao, T., Nagy, Z.K., 2015. Cryst. Growth Des. 15, 





6.2 Experimental Section 
In order to demonstrate the advantages of using wet mill on continuous MSMPRC and 
to prove the differences of applying wet mill upstream and downstream, three different 
methods and experimental setups are used in this work. 
 
6.2.1 Method 1: MSMPRC without Wet Mill 
Method 1 is the basic scenario in which only a single stage MSMPRC is used without 
wet mill. The experimental setup used in method 1 is presented in Figure 6.1(a). Both the 
feed vessel and the MSMPRC are 1 L round bottom jacketed glass reactors. Their jackets 
were connected to two temperature baths (Huber, USA). Each temperature bath contains a 
Pt100 thermocouple that was used to measure the process temperature inside the feed 
vessel or MSMPRC. A FBRM S400 probe (Lasentec, USA) was installed in the MSMPRC 
to provide in situ particle chord length information, which was measured every 15 seconds. 
The two temperature baths and FBRM were connected to a supervisory computer to record 
data and perform temperature control. The jacket temperatures of the feed vessel and 
MSMPRC were kept constant at 55 oC and 25 oC, respectively. The agitation speeds were 
350 rpm in both vessels. Paracetamol (Alfa Aesar, USA; purity > 98%) and anhydrous 
ethanol (KOPTEC, USA; purity > 99.5%) were used to prepare a clear 38 oC saturated feed 
solution (0.26 g/g solvent) (Mitchell and Frawley, 2010). A peristaltic pump (Masterflex, 
USA) was installed to transfer clear solution from the feed vessel into the MSMPRC at a 
constant flow rate of 20 mL/min. The slurry volume inside the MSMPRC was maintained 
at 400 mL during operation, therefore the residence time of MSMPRC was 20 minutes. A 




slurry out of the MSMPRC semi-continuously. This transfer unit works great for 
continuous crystallization process since it can avoid problems such as plugging of transfer 
tubing (Hou et al., 2014). In every transfer, the transfer zone was first evacuated by opening 
the vacuum valve for 1 second. Then the transfer zone inlet valve was opened for 1 second 
to draw in slurry from the MSMPRC. Finally, the transfer zone outlet valve and the 
nitrogen gas valve were opened simultaneously for 2 seconds to transfer out the slurry. The 
four valves and the transfer time interval were controlled by a control box automatically to 
maintain the slurry level constant in the MSMPRC. About 13.3 mL slurry was transferred 
every 40 seconds. The product slurry from the transfer unit was reused and dissolved for 
feed solution in order to save materials (Power et al., 2015). In addition, in every 
experiment an offline slurry sample was taken at the 11st residence time, and then filtered 
immediately for microscope image analysis (Kaiser Optical Systems, USA). 
Since the clear startup solution in MSMPRC cannot spontaneously nucleate at 25 oC, 
one particular startup procedure performed in method 1 is dry seeding. For this purpose 
0.10 g (0.1%) paracetamol dry powder (Figure 6.2) was added into the MSMPRC at the 
beginning of the experiment in order to induce nucleation. In methods 2 and 3 when wet 
milling is used, this dry seeding procedure is omitted because of the significantly enhanced 
nucleation rate under the high shear environment. 
 
6.2.2 Method 2: MSMPRC without Wet Mill Operated Downstream in a Recycle Loop 
The equipment setup for method 2 is shown in Figure 6.1(b). A magic LAB rotor-stator 
wet mill (IKA, USA) was installed in a recycle loop with the MSMPRC using a peristaltic 







Figure 6.1. Experimental setup for (a) method 1 (without wet mill), (b) method 2 (with wet 
mill operated downstream) and (c) method 3 (with wet mill operated upstream). The parts 





Wet mill tip speed is a commonly accepted scaling parameter, which is proportional to 
angular speed of the rotor: 
 ts rv D    (6.1) 
where tsv  is the rotor tip speed, rD  is the rotor outer diameter, and   is the rotor angular 
speed (Engstrom et al., 2013). In this work, two angular speeds, 6000 and 10000 rpm, were 
tested in order to investigate the influences of tip speed. In the mill recycle loop, two 
different flow rates (i.e. 50 and 200 mL/min) were used. Turnover number (TO) is one of 
the most important operating parameters, which defines the number of times the slurry is 
recycled through the wet mill in a batch process (Engstrom et al., 2013; Harter et al., 2013).  
 TO mill tot
q t
V
   (6.2) 
where V  is the slurry operating volume, tott  is the total operation time (batch time), and 
millq  is the recycle volumetric flow rate through wet mill. 
We introduce a similar quantity for continuous crystallization coupled with wet milling, 
namely the turnover number per residence time (TOPRT), which defines how frequently 
the slurry in the MSMPRC is milled. The TOPRT (i.e. 2.5 and 10 in our studies) can be 
calculated from the recycle volumetric flow rate through wet mill ( millq ) and the volumetric 
flow rate through MSMPRC ( MSMPRCq ) using the following equation: 





  (6.3) 
where   is the MSMPRC residence time. The total operating volume in this method is also 




the other operating conditions and procedures are exactly the same as in method 1. Since 
wet mill generates a lot of heat during operation, the wet mill jacket is cooled by cooling 
water to maintain the milling temperature at 25 oC. 
 
6.2.3 Method 3: MSMPRC without Wet Mill Operated Upstream as Seed Generator 
Figure 6.1(c) represents the equipment setup used in method 3. The same wet mill with 
same generator configuration was installed between the feeding peristaltic pump and the 
MSMPRC. The clear feed solution was fed into the wet mill at a same flow rate (i.e. 20 
mL/min). The wet mill was operated at 6000 and 10000 rpm, respectively. The other 
procedures and conditions remain the same as in methods 1 and 2. 
 
Figure 6.2. Paracetamol powder seeds used in method 1. 
 
6.3 Results and Discussion 
The three methods discussed in section 2 are implemented in a serious of experiments, 
which are all monitored for around 12 residence times (RT) to capture both startup and 




number, width of size distribution) and two important process qualities (i.e. yield and 
startup duration) are estimated from FBRM information at 11st RT. The wet mill operating 
conditions (i.e. angular speed, TOPRT) and corresponding process and product qualities of 
these experiments are summarized in Table 6.1. In upstream application, TOPRT always 
equals 1 since there is no recycle. This small TOPRT is suitable for upstream application 
since the purpose is to induce high shear primary nucleation mechanism to generate in situ 
seed crystals. However, in downstream application, large TOPRT and high recycling flow 
rate would be preferred since the purpose is to enable secondary nucleation and breakage 
to efficiently reduce particle size and normalize size distribution. 
The MSMPRC process temperature and chord count information at different times are 
presented in Figure 6.3 and Figure 6.4. In general, the process temperatures in MSMPRC 
are well controlled and discrepancies are shown only during startup period. Since the heat 
generated by wet mill is very different in every experiment due to different experimental 
rigs and operating conditions (e.g. flow rates), there are some small differences in the final 
steady-state process temperatures in the MSMPRC among the different experiments. These 
differences are inevitable. However, their influences on nucleation rates and yield are 
negligible since nucleation is controlled in the wet mill, and the wet mill high shear effect 
on nucleation is much stronger than the supersaturation effects caused by small temperature 
differences in the MSMPRC (Allen et al., 2008; Gray et al., 1995; Reguera and Rubi, 2003). 
The startup duration, as well as steady-state SWMCL and total chord counts can be easily 
















where iL  represents the chord length of ith size interval, and if  is the frequency of chord 
length included in the i th interval (Leba et al., 2010). Figure 6.3 and Figure 6.4 clearly 
indicate the fast nucleation kinetics under high shear environment when wet mill is used. 
In both methods 2 and 3, large amount of nuclei is formed at the beginning of the process 
and then washed out from the MSMPRC. Finally, the steady-state is reached when 
nucleation or/and breakage kinetics reach an equilibrium with the wash out speed from the 
MSMPRC. The steady-state is identified based on both the total counts and mean chord 
length. Steady-state is assumed to be reached when both total counts and mean chord length 
do not show any fast increasing or decreasing trend. 
 
Table 6.1. Summary of experimental conditions, process and product qualities using 
methods 1, 2 and 3. 
Experiment No. 1 2 3 4 5 6 
Method 1 2 3 
Wet 
mill 
Speed [rpm] -- 10000 10000 6000 10000 6000 
TOPRT [-] -- 10 2.5 10 1 
Startup duration [RT] 6 6 >11 9 5 3.5 
SWMCL [μm] 71 55 66 64 57 77 
Total counts [#/s] 3700 10300 7300 4100 15100 10100 
CV [-] 1.06 0.97 0.96 1.07 0.92 1.02 
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Steady-state is no reached within 11 residence time
(c)
 
Figure 6.3. Process temperature, FBRM total counts and SWMCL in the MSMPRC in (a) 
experiment 1, (b) experiment 2, (c) experiment 3. Fluctuations in the temperature profile 
in (a) are caused by disturbances from the wet mill cooling water, but their influences on 
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Figure 6.4. Process temperature, FBRM total counts and SWMCL in the MSMPRC in (a) 
experiment 4, (b) experiment 5, (c) experiment 6.  
 
In terms of startup duration, Table 6.1, Figure 6.3 and Figure 6.4 indicate that the use 




duration, especially when wet mill tip speed or TOPRT is low. However, the startup 
duration can be significantly reduced if wet milling is used upstream as a high shear 
nucleator. This is because when used downstream, at the beginning of the process the 
supersaturation is high and particle number is small, therefore the major kinetics inside the 
wet mill is high shear heterogeneous primary nucleation. But as the supersaturation drops 
down and number of particles increases in the MSMPRC, the major kinetics inside the wet 
mill becomes high shear secondary nucleation and breakage. This complex kinetics change 
may not be favorable to startup and can result in longer duration until steady-state is 
achieved. On the other hand, when wet milling is used upstream, the major kinetic is high 
shear heterogeneous primary nucleation only. Secondary nucleation or breakage is 
negligible in this case, since the feed solution is clear and of high supersaturation. The high 
and relatively constant primary nucleation rate achieved inside the wet mill can help the 
system to deplete the supersaturation fast and reach steady-state quickly. Therefore the 
upstream application of wet milling is better than using it downstream considering startup 
duration.  
The SWMCL shown in Table 6.1, Figure 6.3 and Figure 6.4 can be used to infer the 
average particle size achieved. The results indicate that the use of wet milling downstream 
always reduces particle size, especially when the wet mill tip speed and TOPRT are high. 
This is because high shear secondary nucleation and breakage are dominant in the system, 
and growth is completely suppressed in this case. However, when wet mill is used upstream, 
small crystals are obtained when the tip speed is high, whereas large crystals can be 
produced when the tip speed is low. The reason is that high tip speed of wet mill results in 




small amount of supersaturation is available for crystals to grow in the MSMPRC. On the 
contrary, low wet mill tip speed ends up with limited amount of seed crystals and relatively 
high supersaturation in MSMPRC for crystal growth therefore average crystal size is large. 
In addition, in experiment 6 nucleation and growth kinetics are very well decoupled, which 
is also beneficial for achieving large average crystal size. 
The total counts presented in Table 6.1, Figure 6.3 and Figure 6.4 indicate the nucleation 
rate and particle number in each experiment. The application of wet milling always 
increases nucleation rate and particle number, especially when it is used upstream and with 
high tip speed. 
The previous conclusions related to average particle size and particle number can also 
be clearly identified from the square weighted chord length distributions (SWCLD), 
unweighted chord length distributions and relative frequency distributions (Figure 6.5) 
measured at steady-state (11st RT). In addition, width of the chord length distribution can 
be inferred by calculating the CV from the unweighted chord length distribution (Figure 
6.5(b)) using the following equations: 
 























































































































Figure 6.5. (a) SWCLDs, (b) unweighted chord length distributions and (c) unweighted 




where in  represents the chord count within chord length iL , L  is the average chord length, 
and SD  is the standard deviation. The CV summarized in Table 6.1 and the chord length 
and frequency distributions shown in Figure 6.5 prove that applying wet milling either 
upstream or downstream can help narrow down size distribution, especially when high tip 
speed is used. The improved crystal uniformity in downstream wet milling is because of 
the breakage mechanism, whereas in upstream wet milling the improved uniformity is due 
to the uniform seed crystals generated by the wet mill as well as the decoupled nucleation 
and growth mechanisms. The crystal images presented in Figure 6.6 confirm the 
conclusions discussed before in terms of average particle size and width of size distribution. 
Yield increase is another potential advantage of using wet milling in conjunction with 
continuous crystallization due to the significantly enhanced nucleation rate. Since yield is 
a function of both particle number and particle size, a simple yield index (YI) is used to 
estimate the yield from the solid phase FBRM data: 
 
3Yield index (YI) = Square weighted mean chord length Total counts   (6.9) 
The yield index (YI) is a very simple and convenient measure that combines both 
particle size and particle number information which are inferred from chord length and 
chord counts. Due to the limitations of FBRM (e.g. chord length is measured instead of 
particle size), the approach stated above is not accurate for yield calculation. However, it 
is suitable in terms of qualitative comparative analysis of the proposed approaches. The 
results are summarized in Table 6.1 for comparison. The YI indicates that the application 
of rotor-stator wet milling in continuous crystallization system can improve yield under a 




crystallization, the process is operated at steady-state rather than equilibrium state. In our 
experiments, the residence time is only 20 minutes, which means that the steady-state 
operating point in experiment 1 is far from the solubility curve in the phase diagram and 
yield is governed by kinetics rather than thermodynamics.  
 
Figure 6.6. Microscope images for crystals obtained at steady-state (11st RT) in (a) 
experiment 1, (b) experiment 2, (c) experiment 3, (d) experiment 4, (e) experiment 5 and 




Therefore, the wet milling effect on yield improvement is significant and the yield 
obtained in experiment 1 is much smaller than in all the other experiments. These results 
actually also show an additional advantage of the wet mill by its potential to decrease 
equipment size, when residence time is determined by yield rather than required size, since 
higher yield can be achieved by lower residence time due to the increased nucleation rate 
achieved by the wet mill. The smaller crystallizer size for a desired yield can counteract 
some of the increased capital costs related to using the wet mill as an additional equipment 
in the process. This yield improvement is remarkable especially when wet mill is used 
upstream. Because in upstream application, the wet mill works at high supersaturation and 
induces high shear heterogeneous primary nucleation, therefore the nucleation rate 
enhancement is more significant than using it downstream in which secondary nucleation 
and breakage are dominating. 
Although it is true that there are a few foreseeable downsides of integrating wet milling 
with continuous crystallization, such as increased capital cost, complex process design and 
potential risk for temperature sensitive APIs, the results in this work clearly demonstrate 
the benefits of the integrated continuous wet milling-crystallization (CWMC) process to 
achieve better control of the CSD and yield and also indicate the benefits of the novel 
configuration of upstream wet mill as a continuous high shear nucleator. Upstream wet 
mill provides an excellent approach to control primary nucleation kinetic, which is 
typically difficult to control due to its stochastic nature. In this work the integration of wet 
milling with MSMPRC is demonstrated but the results and conclusions are also valid for 








A high shear rotor-stator wet mill is applied upstream and downstream of a continuous 
MSMPRC. The wet mill becomes a continuous seed generator when it is used upstream 
because of the high shear heterogeneous primary nucleation kinetic that characterizes the 
system. In addition, the wet mill can be used as a continuous size reduction tool when 
applied downstream from MSMPRC due to the controlled secondary nucleation and 
breakage mechanisms. It is found that the downstream application of wet milling may 
increase slightly startup duration. However, startup duration can be significantly reduced 
if wet milling is used upstream as a continuous nucleator. In addition, using wet mill 
downstream can efficiently reduce average particle size and narrow size distribution. On 
the other hand, not only small and uniform crystals, but also large and uniform crystals can 
be achieved by applying wet milling upstream and properly controlling the tip speed. 
Finally, wet milling used in conjunction with continuous crystallization was found to 
significantly enhance yield especially when used upstream as a high shear nucleator due to 
the improved nucleation kinetics. Therefore, in general applying rotor-stator wet milling 
upstream as a continuous in situ seed generator is very promising to achieve an integrated 
and intensified process of high yield and quick startup, and good product qualities (i.e. 





CHAPTER 7. AUTOMATED DIRECT NUCLEATION CONTROL IN CONTINUOUS 
MIXED SUSPENSION MIXED PRODUCT REMOVAL COOLING 
CRYSTALLIZATION11 
7.1 Introduction 
The works that have been done so far in literature in continuous MSMPRC are either 
without process control or with open-loop control only. In addition, the vast majority of 
works described in literature that focus on optimization and control aspects related to 
MSMPRC are theoretical simulation studies only. Therefore, the experimental 
implementation of some practical control methodology is necessary in the development of 
continuous crystallization, to bring theoretical advances in the realm of possibilities. 
This chapter is the first that implements a closed-loop (feedback) control in a continuous 
crystallization process in practice using PAT tool. In this work, a FBRM-based feedback 
control approach, which is modified from batch ADNC (Abu Bakar et al., 2009; Saleemi 
et al., 2012a, 2012b) to accommodate the requirement for steady-state operation in 
continuous crystallization, is proposed and implemented in single-stage and two-stage 
continuous MSMPRC. An API, paracetamol, is used as the model compound in ethanol 
solvent in a continuous cooling crystallization process. 
                                                 
11 Reproduced with permission from Yang, Y., Song, L., Nagy, Z.K., 2015. Cryst. Growth Des. 15, 5839–




7.2 Experimental Section 
The experiments were carried out in a continuous two-stage MSMPRC (Figure 7.1). 
Three 1 liter jacketed round bottom crystallizers were used as feed vessel, first stage 
MSMPRC and second stage MSMPRC, respectively. The jackets of the three vessels were 
connected to three temperature circulators (Ministat 125 with Pilot ONE, Huber, USA), in 
which jacket control (internal control) model was selected. Each MSMPRC stage was 
equipped with a focused beam reflectance measurement (FBRM) probe (S400 and G400, 
Mettler-Toledo, USA) and a Pt100 thermocouple. The particle chord counts and process 
temperature in each stage were measured every 15 seconds and transferred into a Labview 
based software Crystallization Monitoring and Control (CryMOCO) or Crystallization 
Process Informatics System (CryPRINS), which was installed on a supervisory computer. 
This real-time data was then used in the ADNC approach to automatically modify 
temperature set-points in the temperature circulators through CryMOCO. The data were 
communicated via RS232 interface. 
A 38 oC saturated paracetamol (Purity > 98%; Alfa Aesar, USA) - ethanol (Purity > 
99%; KOPTEC, USA) solution (0.26 g/g ethanol) was used as feed solution (Mitchell and 
Frawley, 2010). This clear feed solution was transferred from the feed vessel into the first 
stage MSMPRC through a peristaltic pump (L/S digital pump, Masterflex, USA). The 
slurry obtained in the first stage was then transferred into the second stage semi-
continuously via a transfer unit, which consists of a transfer zone, an inlet valve, an outlet 
valve, a nitrogen valve and a vacuum valve. The slurry could be firstly drew in from the 
previous stage into transfer zone by vacuum, and then transferred into the next stage via 




from the second stage MSMPRC back into the feed vessel for recycle in order to save 
materials (Power et al., 2015). The solution in the feed vessel was kept at around 1 liter 
and 55 oC. The recycled crystals were observed to dissolve immediately once entered into 
the feed vessel. In addition, the feed solution was used as the initial solution in both 
MSMPRC vessels. Therefore, theoretically the recycled slurry should have same 
concentration as the feed after all solids dissolve, and the influence of recycle on feed 
concentration was negligible. 
 
Figure 7.1. Experimental setup of continuous two-stage MSMPRC. 
 
The transfer intervals of the two transfer units were controlled in a controller box to 
maintain the slurry volumes constant in both stages (i.e. 300 mL). At the beginning of every 
experiment, 0.10 g paracetamol fine powders (1100 counts/sec) were introduced into the 




after seed crystals were introduced. The purpose is to ensure that the ADNC approach 
controls secondary nucleation rather than primary nucleation, since secondary nucleation 
is generally dominant in MSMPRC systems. 
 
7.3 Continuous ADNC Methodology 
In the proposed continuous ADNC approach, each stage is controlled individually by 
an ADNC loop. For a certain MSMPRC stage, an upper bound and a lower bound of 
particle total chord counts set-point are defined by the user in the ADNC setup in 
CryMOCO. During the continuous crystallization, once the particle total chord counts 
measured by the FBRM in that MSMPRC stage is found higher than the upper bound, a 
fast heating will be actuated automatically by the ADNC to reduce nucleation rate or trigger 
controlled dissolution (Figure 7.2) in that stage. The fast heating will change to slow 
heating once the measured total counts drops below upper bound. Similarly, fast cooling 
or slow cooling is implemented automatically by ADNC if the measured total chord counts 
is below lower bound or increases above lower bound. The CryMOCO user interface for 
ADNC implementation is presented in Figure 7.3, from which the total chord counts set-
point upper bound, lower bound, fast heating rate and fast cooling rate can be specified. 
Slow heating and slow cooling rates are defined from heating gain ( hK  ) and cooling gain 
( cK  ) (Figure 7.3) based on the following equations: 
 
Fast heating rate
Slow heating rate = 
hK
  (7.1) 
 
Fast cooling rate
Slow cooling rate = 
cK




Since steady-state operation is desired in continuous crystallization, extremely large 
heating and cooling gains (i.e. 255) are used in this work so that slow heating and slow 
cooling rates become practically 0. In other words, the temperature set-point will remain 
constant once the measured total chord counts fall between the upper and the lower bounds. 
In addition, maximum and minimum temperature set-points allowed can also be defined in 
ADNC in CryMOCO (Figure 7.3). 
 
Figure 7.2. ADNC set-point and heating/cooling algorithm. 
 
 
Figure 7.3. CryMOCO user interface for ADNC implementation. 
 
In this chapter, a series of experiments were carried out in single-stage and two-stage 
MSMPRC, with and without using ADNC approach. In the two-stage MSMPRC the use 




in the second stage. The detailed operating conditions and ADNC parameters are 
summarized in Table 7.1. 
 
Table 7.1. Operating conditions and ADNC parameters used in every experiment. 
No. No. of 
stages 
Residence time 
in each stage 
[min] 









20 No ADNC -- -- 
2 20 First ±0.1 3 – 50 
3 Two-
stage 
20 No ADNC -- -- 
4 20 Second ±0.1 3 – 50 
5 75 First and second ±0.05 15 – 26 
6 20 Second ±0.1 3 – 50 
 
7.4 Results and Discussion 
7.4.1 Startup and Control of CSD 
7.4.1.1 Continuous ADNC in Single-Stage MSMPRC 
Experiments 1 and 2 are from single-stage MSMPRC. In experiment 1, ADNC is turned 
off and the jacket temperature of MSMPRC is kept constant at 25 oC. In experiment 2, the 
initial jacket temperature of MSMPRC is also 25 oC, but ADNC is switched on 
immediately after seed crystals are introduced. The process temperature, ADNC jacket set-
point, FBRM total chord counts, ADNC total counts set-point and SWMCL of these two 
experiments are compared in Figure 7.4. It is observed that the total counts increases slowly 
and 6 residence time (RT) is required to reach steady-state in experiment 1 when ADNC is 




MSMPRC decreases automatically at the beginning of the startup to force the system to 
nucleate faster and reach the desired total counts set-point sooner. As a result, only 4 RT 
is spent to reach steady-state in experiment 2 (Figure 7.4(b)). Therefore, ADNC is able to 
reduce significantly the startup duration in a single-stage MSMPRC. It should be noted that 
the steady-state is identified qualitatively based on both the total counts and mean chord 
length. For experiments without ADNC, steady-state is considered reached when both total 
counts and mean chord length do not show any clear increasing or decreasing trend. For 
the experiments with ADNC, steady-state is considered reached when the total counts is 
kept closely between the maximum and minimum values of the total counts set-points, and 
mean chord length does not show any clear increasing or decreasing trend. The steady-state 
criteria cannot be mathematically quantified here due to the nature of FBRM measurement, 
which shows high sensitivity to noise or disturbance, such as fouling and particles adhered 
on probe window, as well as variations in the mixing conditions. In our setup, the slurry is 
transferred using high pressure nitrogen gas, which can cause short spikes and variations 
in the FBRM measurements even under practically steady-state operation. 
In addition, in experiment 2 the ADNC set-point is modified in CryMOCO after the 
system reaches steady-state 1. The purpose is to characterize the ADNC performance when 
a set-point change is required, as well as to compare the crystal chord length distribution 
(CLD) obtained at steady-states at different set-points. It is found that only 0.7 RT is 
required for ADNC to move the system from steady-state 1 into steady-state 2 (Figure 
7.4(b)). The CLD obtained in both steady-states are compared in Figure 7.5. The results 
clearly indicate that when ADNC is used, larger ADNC total counts set-point results in 




is a nucleation dominated compound. This phenomenon agrees with simulation study in 
literature which shows that there is a tradeoff between average crystal size and yield within 
fixed MSMPRC setup and operating constraints (Yang and Nagy, 2015a, 2015b). 















































































































































Figure 7.4. Process temperature, ADNC jacket set-point, FBRM total chord counts, ADNC 
total counts set-point and SWMCL in single-stage MSMPRC: (a) without ADNC 
(experiment 1), (b) with ADNC (experiment 2). 
 
This observation also provides an approach to control product CSD according to 
formulation requirements by manipulating the ADNC set-point. It is considered that once 
the experimental setup, feed concentration and residence times are fixed, the average 




particle size, the first step is to find out a target particle number, which corresponds to the 
target average particle size. This would require a few preliminary experiments to determine 
a correlation or calibration relationship, which then can be used to obtain the target particle 
count corresponding to a desired size. Once the target particle number is found out, the 
target average particle size can be achieved by controlling the particle number using the 
ADNC approach. In general, for paracetamol system it is observed that a relatively small 
ADNC set-point should be used to avoid strong nucleation when fine crystals are not 
desired, and vice versa. The crystal images (Figure 7.6) confirm that more fine particles 























Figure 7.5. Crystal chord length distribution (CLD) at steady-state 1 and steady-state 2 in 
experiment 2 when ADNC is used in single-stage MSMPRC. 
 
In addition, theoretically as long as the final operating temperatures or particle numbers 
are fixed, whether the continuous ADNC approach is used or not during startup, or how 




crystal size, since all the crystals are continuously washed out, and once the ADNC set-
point stabilized the steady-state CSD will be reached. However, under certain conditions, 
in practice it might be observed that using the ADNC during startup leads to larger average 
size than without ADNC (Figure 7.6) when steady-state is reached. This is because the 
ADNC thermo cycles can dissolve fine particles and produce some very large particles 
(Abu Bakar et al., 2009; Saleemi et al., 2012a, 2012b), which are very difficult to be washed 
out. 
 
Figure 7.6. Crystal microscope images of (a) experiment 1, (b) experiment 2 steady-state 
1, and (c) experiment 2 steady-state 2. 
 
7.4.1.2 Continuous ADNC in Two-Stage MSMPRC 
Two-stage MSMPRC is used in experiment 3, 4 and 5. Experiment 3 is the base case in 
which ADNC is not used and the jacket set-points of the first and the second MSMPRC 
are kept constant at 25 oC and 19 oC, respectively. Since the advantages of ADNC on the 
first stage has already been observed in section 7.4.1.1, the effects of applying ADNC on 
the second stage is investigated in experiment 4, in which the jacket set-point of the first 




19 oC before turning on ADNC. The second stage of these two experiments are compared 
in Figure 7.7.  
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Figure 7.7. Process temperature, ADNC jacket set-point, FBRM total chord counts, ADNC 
total counts set-point and SWMCL in the second stage: (a) without ADNC (experiment 3), 
(b) with ADNC implemented in the second stage (experiment 4). The variation in total 
counts between 3.5 and 4 RT is due to probe fouling and cleaning. 
 
It is observed that the startup duration can be reduced from 5 RT to only 2.5 RT when 
ADNC is used in the second stage. In addition, sometimes sharp jumps of total counts or 
mean chord length may be noticed, such as total counts between 3.5 RT to 4 RT in Figure 




the window of the FBRM probe. The total counts signal returns to its original value 
immediately after the probe window is cleaned at 4 RT. Since the ADNC is based on the 
FBRM total counts measurement only, the false signal of mean chord length will not 
influence the control performance, however the false signal of total counts can disrupt the 
control algorithm. Therefore, it is very important to ensure that the FBRM window is clean 
during operation. The window must be cleaned as soon as abnormal data jump is observed 
in the signal. 
A set-point change in ADNC is also implemented in experiment 4 in the second stage 
(Figure 7.7(b)). Around 2.3 RT is used for the system to move from steady-state 1 to 
steady-state 2. The CLD obtained from these two steady-states are compared in Figure 7.8, 
which indicates that in the ADNC approach, smaller ADNC set-point results in larger 





















Figure 7.8. CLD at steady-state 1 and steady-state 2 in experiment 4 when ADNC is used 





Therefore, similarly as in the case of the single-stage system, the CSD can be controlled 
in two-stage MSMPRC by manipulating the ADNC set-point in the second stage. Crystal 
images in Figure 7.9 also show that average crystal size is increased from steady-state 1 to 
steady-state 2 due to a decreased ADNC set-point. 
 
Figure 7.9. Crystal microscope images of (a) experiment 3, (b) experiment 4 steady-state 
1, and (c) experiment 4 steady-state 2. 
 
In previous experiments, the RT in each stage is relatively short (i.e. 20 minutes), and 
ADNC is used only in one of the two stages. Therefore, experiment 5 is performed in order 
to test the feasibility of applying ADNC in systems that have long residence time, as well 
as the possibility of using ADNC simultaneously in more than one stage. The RT of each 
stage in experiment 5 is 75 minutes. Two ADNC loops are used in the first and the second 
stage simultaneously. The FBRM and temperature data of both stages are presented in 
Figure 7.10. The startup durations spent in the first and the second stage are only 2.4 RT 
and 3 RT, respectively. This observation once again shows the ability of the ADNC 
approach to provide quick startup. Two steady-state operating conditions are evaluated in 
experiment 5 by changing the ADNC set-point in the second stage. In this case it takes only 




The ability of the ADNC approach to control the CSD is also observed here based on the 
comparisons of CLD (Figure 7.11) and microscope images (Figure 7.12) in the two steady-
states. The results clearly indicate that large and uniform crystals (Figure 7.12(a)) can be 
obtained by the ADNC if the set-point is properly chosen, whereas fine particles may be 
generated (Figure 7.12(b)) if the set-point is selected to be at larger counts/sec. 
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Figure 7.10. Process temperature, ADNC jacket set-point, FBRM total chord counts, 
ADNC total counts set-point and SWMCL in (a) first stage with ADNC (experiment 5), (b) 
second stage with ADNC (experiment 5). 
 
The experiments previously discussed indicate that the length of residence time will not 




or in multiple stages simultaneously. Although only two-stage MSMPRC is implemented 
here, in principle there should be no problem to apply ANDC in MSMPRC of more than 
























Figure 7.11. CLD at steady-state 1 and steady-state 2 in experiment 5 when ADNC is used 
in both stages. 
  
Figure 7.12. Crystal microscope images of (a) experiment 5 steady-state 1, (b) experiment 
5 steady-state 2. 
 
Additionally, this approach allows to control nucleation quantitatively in every stage if 




example, nucleation and the generation of fine particles in the second stage might be 
completely avoided by selecting a same ADNC set-point in both the first and the second 
stages. More generally, in a multi-stage MSMPRC with the ADNC applied and FBRM 
data calibrated in all stages, for a given starting solution concentration or saturation 
temperature, if large particle size is desired, same or similar maximum/minimum total 
counts set-points should be used in all stages so that nucleation after the first stage can be 
minimized or completely avoided. The values of these total counts set-points can be then 
tuned based on the yield requirement. On the other hand, if small particle size and high 
yield are required, the maximum/minimum total counts set-points of the second or 
subsequent stages should be as larger in order to maximize nucleation and minimize growth. 
 
7.4.2 Disturbance Suppression 
Since ADNC is a feedback control approach, in principle it should be able to help 
suppress disturbances. Experiment 6 is a follow up of experiment 3 after steady-state is 
reached. As shown in Figure 7.13, disturbance 1 and disturbance 2 are the same artificial 
pulse disturbances of adding 0.5 g paracetamol fine powders into the second stage to 
disrupt the steady-state. This could be for example a practical disturbance that may occur 
from accidental seeding from an encrust layer that may form on the walls or stirrer shaft 
during the continuous crystallization operation. ADNC is turned off when disturbance 1 is 
introduced but turned on before introducing disturbance 2. It is found that 1.7 RT is 
required to wash out the fine particles without ADNC. However, when ADNC is used, the 
MSMPRC can automatically heat up to dissolve the fine particles therefore they are 




by using ADNC. The CLD in Figure 7.14 shows that ADNC can provide exactly same 
good performance as the simple washing out approach to adjust the CLD back into the 
original steady-state. But less time is required and less products are wasted if ADNC is 
used.  
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Figure 7.13. Process temperature, ADNC jacket set-point, FBRM total chord counts, 
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In addition, ADNC should have advantages on suppressing not only pulse disturbance 
but also continuous disturbance (e.g. step disturbance). For example, if a feed solution that 
has higher concentration than nominal concentration is used, ADNC should be able to 
detect the increased nucleation rate therefore increase the MSMPRC temperature 
accordingly to maintain the total particle chord counts within the ADNC set-point and as a 
result maintain the average crystal size. However, system without ADNC cannot react to 
the feed concentration increase. It will end up with smaller crystal size than the desired. 
The operating temperature has to be re-designed manually in order to work for a different 
feed concentration without ADNC. Therefore, ADNC can significantly improve the 
robustness of continuous MSMPRC. Additionally, this study shows that the proposed 
closed-loop ADNC approach is stable and total counts can converge to the desired set-point 
under selected control parameters. However, it is observed that this closed-loop approach 
becomes unstable when too large heating and cooling rates are used. There are two 
potential causes for instability under such aggressive parameters. First of all, the actual 
process temperature will have significant delay compared to the calculated temperature set-
point. Additionally, the temperature change will be too fast compared to the crystallization 
kinetics for the process to be able to respond. Therefore a few preliminary experiments are 
required to tune the control parameters when a new experimental setup or compound is 
introduced for ADNC application. 
Finally, as already described in chapter 2, SSC is another widely used feedback control 
approach that uses concentration measurement to adjust temperature set-point in batch 
cooling crystallization. Since in this work ADNC is observed to have superior performance 




startup duration, control CSD and suppress disturbance in continuous MSMPRC. Low cost 
PAT imaging tools can also be used in the process as a supplement for FBRM or UV/Vis 
spectroscopy to monitor and control CSD (Simon et al., 2012). 
 
7.5 Conclusions 
In this chapter, a FBRM-based feedback control approach, named as ADNC, is 
implemented in single-stage and two-stage MSMPRC. Based on the in situ FBRM 
information, ADNC can automatically actuate heating or cooling to control the total 
particle chord counts within the ADNC set-point range during both startup and steady-state 
operations. It is found that the proposed continuous ADNC approach can significantly 
reduce the startup duration. In addition, the steady-state CSD can be controlled by adjusting 
the ADNC set-point. Large crystals can be obtained if the ADNC set-point is properly 
selected to avoid nucleation in the second stage. Finally, ADNC is observed to provide 




CHAPTER 8. APPLICATION OF WET MILLING-BASED AUTOMATED DIRECT 
NUCLEATION CONTROL IN CONTINUOUS COOLING CRYSTALLIZATION 
PROCESSES12 
8.1 Introduction 
Chapter 6 reported that very uniform crystals can be obtained by integrating a wet mill 
unit with continuous MSMPRC (Yang et al., 2015d). The advantages of integrating wet 
milling (WM) into continuous crystallization, such as improved yield and narrowed size 
distribution, have been observed. However, there was no process control framework 
implemented in the study of this WM technique. In addition, Chapter 7 introduced a FBRM 
based feedback control approach for cascade MSMPRC systems by extending the ADNC 
approach developed originally for batch crystallization processes (Yang et al., 2015e). In 
this ADNC approach the crystal size is controlled by manipulating the MSMPRC jacket 
temperature and nucleation kinetics. However, one potential limitation of this ADNC 
technique is that the nucleation in MSMPRC cannot be separated from growth therefore 
this nucleation control approach will always be also influenced by the growth kinetics in 
the MSMPRC.
                                                 
12 Reproduced with permission from Yang, Y., Song, L., Zhang, Y., Nagy, Z.K., 2016. Ind. Eng. Chem. Res. 





Therefore, in this chapter, we would like to introduce a novel approach called 
WMADNC, which is a technique that combines the advantages of WM and ADNC. This 
approach is aligned with both the QbD and the new QbC concept in pharmaceutical 
manufacturing (Yang et al., 2015e). It implements the continuous ADNC closed-loop 
approach in a continuous wet mill unit which behaves as a perfect nucleator. The idea is to 
use the total particle chord counts measured by FBRM in the crystallizer to manipulate the 
jacket temperature of the wet mill in closed-loop. By manipulating the temperature in the 
wet mill the supersaturation at which nucleation happens is controlled. Because of the very 
short residence time in the wet mill this approach controls the nucleation kinetics directly 
in the wet mill without being influenced by the growth kinetics. The proposed WMADNC 
concept is integrated with a continuous MSMPRC in both upstream and downstream 
configurations to achieve closed-loop controlled primary or secondary nucleation kinetics. 
This WMADNC approach should not only contain all the advantages of WM and ADNC, 
but also have better control performance on particle size due to decoupled nucleation and 
growth kinetics. Paracetamol, which is an API, and ethanol are used as solute and solvent, 
respectively. Performances of WMADNC under startup, steady-state, set-point change and 
disturbance are studied for continuous cooling crystallization in the MSMPRC. 
 
8.2 Experimental Section 
8.2.1 Upstream Application of WMADNC Approach (Process 1) 
The experimental setup for process 1 is shown in Figure 8.1(a). The feed vessel and 
MSMPRC were 1 liter round bottom jacketed vessel. A magic LAB rotor-stator wet mill 




generators were used in the wet mill. The angular speed of the wet mill was set to 10,000 
rpm in all the experiments. Three temperature bathes (Huber) were connected to the jackets 
of feed vessel, MSMPRC and wet mill. Clear feed solution was transferred from the feed 
vessel directly into the wet mill through a peristaltic pump (Masterflex). Both wet mill and 
MSMPRC were equipped with thermocouples to measure the process temperatures. In 
addition, a FBRM ParticleTrack G400 probe (Mettler-Toledo) was installed in the 
MSMPRC to provide real-time information of particle chord counts and CLD. The FBRM 
information was measured every 15 seconds and collected in the software iC FBRM 4.3, 
which communicated via an RS232 interface with the CryMOCO software that was 
installed on a supervisory computer. All temperature measurements were also collected in 
CryMOCO. Slurry from the MSMPRC was transferred out semi-continuously through a 
transfer unit that used vacuum and nitrogen gas.  
The feed solution was prepared from paracetamol (Alfa Aesar, purity > 98%) and 
ethanol (KOPTEC, purity > 99%) at a concentration of 0.26 g/g, which corresponds to 
solubility at 38 oC (Mitchell and Frawley, 2010). The feed flow rate was kept at 20 mL/min 
in all the experiments. Every 40 seconds around 13 mL slurry was transferred out from the 
MSMPRC through the transfer unit. The total volume including wet mill and MSMPRC 
was maintained at around 400 mL. Therefore, the total RT was 20 minutes. The jacket 
temperatures of feed vessel and MSMPRC were kept at 55 oC and 25 oC, respectively, in 
all the experiments. The feed solution, final stage temperature and residence times are the 
same for all the experiments, therefore the yields are comparable in all the experiments. 
The product slurry was recycled for preparing feed solutions in order to save API (Power 




filtered immediately. The sample crystal images were taken using SMZ1500 optical 
microscope (Nikon). DXR Raman microscope (Thermo Scientific) was used for 
polymorph analysis with 532 nm laser wavelength and 8 mW laser power. 
 
8.2.2 Downstream Application of WMADNC Approach (Process 2) 
Figure 8.1(b) presents the experimental setup for process 2. Compared to process 1, the 
only difference was that the wet mill was connected to the MSMPRC through external 
recycling. In this case the wet mill worked as a downstream size reduction unit under high 
shear secondary nucleation and breakage mechanisms. All the process operating conditions 
(e.g. feed flow rate, operating volume, temperatures, etc.), wet mill configurations (e.g. 
generators, angular speed) and measurements settings used in process 2 were exactly the 
same as in process 1. In addition, the recycling flow rate through the wet mill in process 2 
was 200 mL/min, which can be used to calculate the TOPRT (Yang et al., 2015d):  





  (8.1) 
where   is the MSMPRC residence time, millq  and MSMPRCq  are the recycling flow rate 
through wet mill and the feed flow rate through the MSMPRC, respectively. In this case a 
TOPRT = 10 was used. The physical meaning of this TOPRT value is that on average, the 
slurry was milled 10 times before it was washed out from the MSMPRC. The TOPRT is 
an important operating parameter in integrated continuous crystallization and wet milling 











8.2.3 WMADNC Methodology in Continuous Cooling Crystallization 
WMADNC is a FBRM based closed-loop (feedback) control approach that we propose 
to control primary nucleation in process 1, or secondary nucleation in process 2 directly in 
the wet mill therefore control the final CLD. Both primary and secondary nucleation 
kinetics are strong functions of supersaturation: 
 prim
n




sec secB k c m    (8.3) 
where 
primB  and secB  are primary and secondary nucleation rates, primk  and seck  are 
primary and secondary nucleation rate constants, 
primn  and secn  are primary and secondary 
nucleation orders, c  is absolute supersaturation, and 2m  is the second moment of the 
CSD. Since the real-time particle total chord counts measurement from FBRM can reflect 
total particle number and nucleation kinetics in the system, it is used in the closed-loop 
control to automatically adjust the jacket temperature set-point of the wet mill therefore 
control supersaturation and primary or secondary nucleation rate directly inside the wet 
mill. Similar as the continuous ADNC algorithm (Yang et al., 2015e), first of all an upper 
and a lower bounds for desired particle total chord counts set-point must be defined in 
WMADNC (Figure 8.2). During the operation, if the measured total counts was found 
smaller than the lower bound, a pre-defined cooling rate would be actuated automatically 
by CryMOCO to cool down the wet mill jacket therefore increase supersaturation and 
hence nucleation rate in the wet mill, and vice versa. If the measured total counts fell 
between the upper and the lower bounds, then the wet mill jacket temperature would be 




this work, heating and cooling rates were set as ± 0.1 oC/min in all the experiments that 
used WMADNC. The initial wet mill jacket temperature was set to 20 oC in all the 
experiments. 
 
Figure 8.2. WMADNC methodology. 
 
8.3 Results and Discussion 
8.3.1 Upstream Application of the WMADNC Approach to Achieve Closed-Loop 
Controlled Primary Nucleation (Process 1) 
In process 1 (Figure 8.1(a)), the wet mill behaves as an upstream in situ seed generator 
under high shear primary nucleation mechanism since the feed solution is clear. It produces 
seed crystals for the MSMPRC, which acts as a growth vessel. WMADNC approach is 
used upstream to achieve closed-loop controlled primary nucleation kinetics. The 
dynamics of process 1 applied with WMADNC approach under startup, steady-state and 




8.3.1.1 Startup and Steady-State Dynamics 
The startup and steady-state dynamics of process 1 with the WMADNC approach 
applied is plotted in Figure 8.3(a), which includes milling outlet temperature, milling jacket 
temperature set-point, FBRM total particle chord counts, WMADNC total counts set-point 
and FBRM SWMCL. The upper and lower bounds of the WMADNC total counts set-point 
are 18,500 and 16,000, respectively.  










 Mill outlet temperature
 Mill jacket setpoint
 Total counts 
 WMANDC set-point
 SWMCL








































































No. of Residence Time (RT) [-]
 Total Counts Without control
 Total Counts With WMADNC
(b)
 
Figure 8.3.(a) Milling outlet temperature and jacket temperature set-point, FBRM total 
particle chord counts, WMADNC total counts set-point, and SWMCL during startup and 
steady-state operation in process 1 with WMADNC approach. (b) Comparison of total 




The fast increase of total counts indicates large primary nucleation rate at the beginning 
of the process. Then once the total counts overshoots above the set-point, it can be seen 
that the WMADNC approach automatically heats up the wet mill jacket to reduce the 
primary nucleation rate. Finally, two oscillations of total counts are observed during startup 
before it converges to the desired WMADNC set-point and steady-state operation. In this 
work, steady-state is assumed reached once the measured total counts are around the 
WMADNC set-point for 2 RT or longer (Yang et al., 2015e). Figure 8.3(b) presents the 
comparison of the total counts dynamics for process 1 with WMADNC approach 
implemented and case without control when mill jacket and outlet temperatures are 
constant. It is clear that both experiments end up with two oscillations during startup and 
reach steady-state at a similar time. Therefore, the WMADNC approach in this case does 
not show any improvement in the startup duration. Because the primary nucleation kinetics 
in wet mill is too fast and too sensitive to supersaturation therefore change in milling 
temperature is unfavorable to stabilize startup. This observation proves that closed-loop 
control for upstream wet mill which works as in situ nucleator is redundant during startup 
operation. 
 
8.3.1.2 Set-Point Change and Control of CLD 
After steady-state 1 is reached in process 1 with WMADNC approach, the upper and 
lower bounds of WMADNC total counts set-point are reduced to 12,500 and 10,000. As 
shown in Figure 8.4, when the total counts set-point is reduced, the wet mill jacket 
temperature automatically increases to decrease supersaturation and hence nucleation rate 




2 very quickly.  The SWMCL in steady-state 2 is much larger than in steady-state 1 due to 
the reduced nucleation rate and increased supersaturation level in the MSMPRC for crystal 
growth.  
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Figure 8.4. Milling outlet temperature and jacket temperature set-point, FBRM total 
particle chord counts, WMADNC total counts set-point, and SWMCL in process 1 with 
WMADNC approach under set-point change. 
 
SWCLDs of these two steady-states shown in Figure 8.5 confirm the increase of average 
crystal size. It is noticed that many more large crystals and less fines can be obtained by 
decreasing the total counts set-point in process 1. Therefore, this WMADNC approach 
provides an efficient and novel way to directly control CLD by adjusting the WMADNC 
total chord counts set-point. Additionally, it can be noticed that at the end of steady-state 1 
zone in Figure 8.4, the total counts drops slightly below set-point lower bound and shows 
a downward trend. This extent of variation of FBRM data is very common in continuous 
MSMPRC experiments in literature (Hou et al., 2014; Peña and Nagy, 2015; Yang et al., 
2015d, 2015e) because of unavoidable disturbances in continuous crystallization 




non-ideal transferring due to not well-mixed slurry, among others. Therefore, perfect 
steady-state operation and FBRM data is never achievable in real experiments, and only 
quasi steady-state is achievable. However, for simplification the term “steady-state” will 
be used in this chapter instead (Yang et al., 2015e). Since the FBRM data has already been 
stabilized for more than 2 RT in steady-state 1, and total counts stopped decreasing right 
after steady-state 1 zone, it is reasonable to assume steady-state 1 is reached and maintained. 
In addition, in Figure 8.4 as soon as the total counts drops below the set-point lower bound, 
it can be seen that the controller actuates a cooling rate to counteract the disturbance, and 
very soon the total counts stopped decreasing. This shows the ability of WMADNC to 
counteract disturbance. More detailed study of WMADNC’s ability to reject disturbance 




























8.3.1.3 Disturbance Rejection 
Since the WMADNC is a closed-loop nucleation control approach, its performance to 
reject disturbance is also evaluated. According to Figure 8.6, at first, process 1 is at steady-
state 2 with the WMADNC approach enabled. Then suddenly a step disturbance is 
introduced on purpose by changing the angular speed of the wet mill from 10,000 rpm to 
6,000 rpm. Decrease of the wet mill angular speed can lead to two opposite effects. On one 
hand, the reduced shear rate decreases nucleation rate. On the other hand, the reduced 
angular speed decreases the energy introduced therefore decreases milling temperature and 
increases supersaturation and primary nucleation rate.  
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Figure 8.6. Milling outlet temperature and jacket temperature set-point, FBRM total 
particle chord counts, WMADNC total counts set-point, and SWMCL in process 1 under 
disturbance with WMADNC approach. 
 
It is observed that the total counts and SWMCL start to decrease and increase, 
respectively, after the step disturbance is introduced. Therefore, in this case the first effect 
is dominating and primary nucleation rate is reduced. But once the measured total counts 




approach which then cools down the wet mill automatically to enhance supersaturation and 
nucleation rate in the wet mill. Finally, both total counts and SWMCL are able to return to 
their original values although the disturbance still exists, and steady-state 3 is reached. The 
CLDs of steady-state 2 and steady-state 3 in this test (Figure 8.7) demonstrate that the 






















Figure 8.7. SWCLDs at steady-state 2 and steady-state 3 in process 1 with WMADNC 
implemented upstream. 
 
The microscope images and Raman spectra of crystals obtained in steady-state 1, 
steady-state 2 and steady-state 3 during process 1 servo control (i.e. set-point change) and 
regulatory control (i.e. disturbance change) tests are presented in Figure 8.8 and Figure 8.9, 
respectively. Figure 8.8 confirms that CLD shifts towards larger size from steady-state 1 
to steady-state 2 due to reduced primary nucleation rate, and CLD does not change from 




of samples presented in Figure 8.9 indicate that monoclinic paracetamol (Form I, stable 
form, octahedrons) rather than orthorhombic paracetamol (Form II, metastable form, 
needle-like) crystals are obtained in all three steady-states (Barthe et al., 2008; Nanubolu 
and Burley, 2012; Thorley et al., 2006). This observation agrees with literature in which 
wet mill was found to facilitate the formation of stable form crystals (Lo et al., 2012). 
 
Figure 8.8. Microscope images of crystals obtained in (a) steady-states 1, (b) steady-state 
2 and (c) steady-state 3 in process 1 with WMADNC implemented upstream. 

























Figure 8.9. Raman spectra of crystals obtained in steady-state 1, steady-state 2 and steady-




8.3.2 Downstream Application of the WMADNC Approach to Achieve Closed-Loop 
Controlled Secondary Nucleation (Process 2) 
In process 2 (Figure 8.1(b)), the wet mill works as a downstream size reduction unit 
under high shear secondary nucleation and breakage mechanisms. It can efficiently reduce 
crystal size. The WMADNC approach is used downstream to achieve closed-loop 
controlled secondary nucleation kinetics. The application of the WMADNC approach in 
process 2 under startup, steady-state and disturbance are investigated next. 
 
8.3.2.1 Startup and Steady-State Dynamics 
Process variables during operation of process 2 with the WMADNC approach enabled 
are presented in Figure 8.10(a). The upper and lower bounds of the WMADNC set-point 
are selected as 13,000 and 10,000, respectively. Within the first RT, the particle total chord 
counts increases very fast due to the high shear enhanced secondary nucleation kinetics, 
which leads to an overshoot of the total counts. As a result, the WMADNC approach heats 
up the wet mill jacket to reduce supersaturation and secondary nucleation rate. Finally, the 
total counts automatically converges to the selected set-point after one oscillation. Figure 
8.10(b) presents a comparison of total counts in process 2 without control (i.e. constant 
mill temperature) and with WMADNC approach. Similar as in process 1, WMADNC 
approach does not improve startup in process 2 either. This again confirms that change in 
milling temperature is unfavorable to stabilize the startup dynamics since the nucleation 
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Figure 8.10. (a) Milling outlet temperature and jacket temperature set-point, FBRM total 
particle chord counts, WMADNC total counts set-point, and SWMCL during startup and 
steady-state operation in process 2 with WMADNC approach. (b) Comparison of total 
particle chord counts dynamics in process 2 without control and with WMADNC approach. 
 
8.3.2.2 Set-Point Change and Control of CLD 
As shown in Figure 8.11, the upper and lower bounds of the WMADNC set-point are 
reduced to 8,000 and 6,000, respectively, when the process is at steady-state 1. This set-
point change results in the WMADNC adapting the heating of the wet mill jacket to 
decrease supersaturation and secondary nucleation rate. The total counts is able to reach 




SWMCL increases from steady-state 1 to steady-state 2. In addition, the SWCLDs of both 
steady-states are compared in Figure 8.12.  
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Figure 8.11. Milling outlet temperature and jacket temperature set-point, FBRM total 
particle chord counts, WMADNC total counts set-point, and SWMCL in process 2 with 




























It is clear that the number of fine crystals decreases significantly from steady-state 1 to 
steady-state 2. This also provides an excellent approach to tailor CLD and control the 
number of fine crystals in the system by adjusting the WMADNC set-point. 
 
8.3.2.3 Disturbance Rejection 
The closed-loop disturbance rejection performance of the WMADNC approach in 
process 2 is also tested. As shown in Figure 8.13, the wet mill angular speed is suddenly 
changed from 10,000 rpm to 13,000 rpm when the system is at steady-state. The two 
opposite effects of changing wet mill angular speed described in process 1 also exist in this 
process. 
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Figure 8.13. Milling outlet temperature and jacket temperature set-point, FBRM total 
particle chord counts, WMADNC total counts set-point, and SWMCL in process 2 with 
WMADNC approach under disturbance. 
 
It is clear that in this process the temperature effect of wet milling is dominating, and 
total counts and SWMCL begin to decrease and increase respectively due to increased 




automatically activates the WMADNC approach, which cools down the wet mill jacket 
immediately and finally brings total counts and SWMCL back to their initial steady-state 
values. The SWCLDs shown in Figure 8.14 confirm that the step disturbance is completely 





















Figure 8.14. SWCLDs of steady-state 5 and steady-state 6 in process 2 with WMADNC 
implemented downstream. 
 
Figure 8.15 and Figure 8.16 present the microscope images and Raman spectra of 
crystals obtained in steady-state 4, steady-state 5 and steady-state 6 in process 2, 
respectively. The results confirm that less fine particles are present in steady-state 5 than 
steady-state 4 due to reduced secondary nucleation rate, and the disturbance introduced 
does not change the CLD from steady-state 5 to steady-state 6. In addition, the stable form 
of paracetamol (Form I) is obtained in all three steady-states, indicated by the identical 





Figure 8.15. Microscope images of crystals obtained in (a) steady-states 4, (b) steady-state 
5 and (c) steady-state 6 in process 2 with WMADNC implemented downstream. 


























Figure 8.16. Raman spectra of crystals obtained in steady-state 4, steady-state 5 and steady-
state 6 in process 2 with WMADNC implemented downstream. 
 
The FBRM based closed-loop WMADNC approach described in this work should be 
applicable to not only continuous MSMPRC, but also other types of continuous 
crystallizers such as continuous plug flow crystallizer. It can be envisioned that both 




plug flow crystallization processes to achieve closed-loop controlled primary or secondary 
nucleation kinetics, therefore provide superior control on CLD and reject disturbances. In 
addition, the proposed WMADNC approach does not require any modelling effort or 
knowledge about solubility or crystallization kinetics of the compound. The only 
requirement is a few experiments to tune the control parameters such as heating and cooling 
rates. Therefore, the WMADNC approach provides a very fast approach for highly 
automated recipe design for continuous crystallization processes. 
 
8.4 Conclusions 
A closed-loop WMADNC approach is proposed and implemented in laboratory scale 
integrated continuous MSMPRC-wet mill system. The proposed approach is demonstrated 
to provide closed-loop controlled primary or secondary nucleation kinetics by using it 
upstream or downstream in continuous cooling crystallization. Closed-loop WMADNC 
approach does not show any improvement in the startup of either applications, which 
indicates that closed-loop control is redundant for wet milling during startup. However, 
during steady-state operation, the proposed WMADNC is proved to be an excellent 
approach to tailor CLD by adjusting the total chord counts set-point in both applications 
therefore can directly control the CQA.  In addition, WMADNC can provide very fast and 
effective disturbance rejections. Same CLD can be achieved consistently under 




CHAPTER 9. APPLICATION OF ULTRA-PERFORMANCE LIQUID 
CHROMATOGRAPHY AS AN ONLINE PROCESS ANALYTICAL 
TECHNOLOGY TOOL IN PHARMACEUTICAL CRYSTALLIZATION13 
9.1 Introduction 
This chapter presents the initial application of UPLC combined with automated online 
process sampling and dilution as a PAT tool for the systematic study of pharmaceutical 
crystallization. Crystallization of two APIs, including caffeine and acetylsalicylic acid 
(ASA, or aspirin) were investigated. The first section demonstrates how online UPLC can 
be implemented as a method for concentration measurement in crystallization and 
degradation of APIs. The second section compares online UPLC with common 
spectroscopy techniques (i.e. ATR-UV/vis and Raman) and introduces a novel method that 
uses online UPLC data to simplify the spectroscopy calibration process. The new method 
can be fully automated and can serve as a continuous probe validation and recalibration 
procedure. The last section describes development and verification of online UPLC for 
real-time crystallization product purity monitoring.
                                                 
13 Reproduced with permission from Cryst. Growth Des., submitted for publication. Unpublished work 




9.2 Experimental Section 
9.2.1 Materials 
Caffeine and aspirin (ASA) were studied as model APIs in this work. Salicylic acid 
(SA) or paracetamol (PCM) were spiked as impurities in the aspirin crystallization process. 
Water, acetonitrile (ACN), methanol (MeOH), and acetic acid (AA) were used in mobile 
phases in UPLC methods for different compounds. The manufacturer and purity of 
materials used in this work are summarized in Table 9.1. 
 
Table 9.1. Manufacturer and purity of materials used. 
Name Manufacturer Purity or Grade 
Caffeine Fisher Chemical ≥98.5% 
Aspirin (ASA) Alfa Aesar ≥99% 
Salicylic acid (SA) Fisher Chemical ≥99.5% 
Paracetamol (PCM) ACROS Organics ≥98% 
Water Fisher Chemical Optima LC/MS grade 
Acetonitrile (ACN) Fisher Chemical Optima LC/MS grade 
Methanol (MeOH) Fisher Chemical Optima LC/MS grade 
Acetic acid (AA) Fisher Chemical ≥99.5% 
 
9.2.2 Experimental Setup 
The experimental setup is presented in Figure 9.1. The crystallizer was a one-liter 
jacketed glass vessel (LABTEX) with overhead stirring, which was connected to a 
refrigerated/heated circulating temperature bath (Huber, Ministat 125). FBRM (Mettler-
Toledo, G400, software IC FBRM 4.3), ATR-UV/vis (Zeiss, MCS621, software 




software IC Raman 4.1), a Pt100 thermocouple and a condenser were installed on the 
crystallizer. The in situ measurements from the above tools were communicated to 
CryMOCO, also called CryPRINS via an RS232 interface (Yang et al., 2015d, 2015e, 
2016). The temperature bath was controlled by CryMOCO in closed-loop. The online 
UPLC system with integral process sampling and dilution used in this work (Waters, 
PATROL UPLC®, with Empower 3 software) consists of binary solvent manager, process 
sample manager, column manager and an UV detector. A stainless steel inlet solvent filter 
with 2 µm pore size (Upchurch Scientific) was installed at the end of the PATROL UPLC® 
process sample line immersed in the crystallizer to enable sampling of just the mother 
liquor from the crystallization slurry. The PATROL UPLC® process sample manager 
outline was routed back to the vessel to recycle and conserve unused sample solution. 
Robust sampling for online UPLC from hot supersaturated crystallization solutions was 
challenging due to the strong potential for APIs to precipitate and clog the sampling loop. 
To avoid these problems, the process sample line, recycle line and all of the process sample 
manager sample tubing were enwrapped by specially designed tubing heaters that were 
connected to a power supply providing heating current. Additionally, hot air was blown 
into the process sample manager to keep the sample valve and injection valve hot. The 
temperatures of tubing heaters and hot air were controlled as 10–15 oC higher than the 
maximum saturation temperature of the solution. To avoid the influence of dead volume 
during each measurement, the process sample line was primed by 2 mL sample before auto-






Figure 9.1. Schematic of experimental setup. 
 
9.2.3 UPLC Methods 
The UPLC methods used in this work are summarized in Table 9.2. Representative 
chromatograms of the three APIs are presented in Figure 9.2. The minimum run time 
required in all three methods was less than 2 minutes.  Combined with the one and half 
minute sampling and dilution of the PATROL UPLC®, a minimum total cycle time of 3.5 
minutes can be achieved. This fast measurement time enabled the use of UPLC as an online 
PAT to achieve real-time process monitoring and control. If the concentration changes very 
slowly or frequent measurement is not required, one can use longer measurement intervals 
by setting up a delay between each measurement in Empower 3 in order to save materials. 




to seven standard solutions of various concentrations and linear least square regression 
analysis (Pickering and Brown, 2012). 
 
Table 9.2. Isocratic UPLC methods used in this work for different compounds. 
 Caffeine Aspirin + impurities 
Column Waters BEH C18 
1.7 µm particles 
2.1*50 mm 
Waters BEH C18 
1.7 µm particles 
2.1*100 mm 
Column temperature 40 oC 40 oC 
Mobile phase A Water 1.5% AA in water 
Mobile phase B ACN MeOH 
Ratio A:B 92:8 55:45 
Flow rate 0.6 mL/min 0.5 mL/min 
Diluent Mobile phase Mobile phase 
UV wavelength 273 nm 275 nm 
Injection volume 2 µL 2 µL 
Dilution factor 100 100 
Run time 1.7 minutes 2.5 minutes 
 




































9.3 Results and Discussion 
9.3.1 Online UPLC-Based Crystallization and Degradation Monitoring 
Caffeine crystallization from water was carried out to demonstrate the use of online 
UPLC for real-time concentration measurement. Caffeine was chosen as the first model 
compound because it is known to have a strong tendency to create fouling (Wu and Bird, 
2007), making it challenging for many PAT tools such as FBRM, PVM and ATR-UV/vis. 
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Figure 9.3. Temperature, concentration, total counts and unweighted mean chord length 
during caffeine crystallization process. 
 
The process parameters, including temperature, concentration measured by online 
UPLC, total chord counts and unweighted mean chord length measured by FBRM, are 
plotted in Figure 9.3. The profile for online UPLC measured concentration agrees well with 
the total chord counts measured from FBRM in terms of the nucleation time, indicating 
that there is minimal delay in the online UPLC measurement. After 5 hours, significant 




chord counts and mean chord length also started to decrease and increase, respectively, due 
to probe fouling. However, Figure 9.3 indicates that the online UPLC continued to provide 
accurate and robust concentration measurement, even in the presence of significant fouling. 
Because UPLC can measure concentrations for multiple components, it is very useful 
for monitoring degradation of unstable APIs. The hydrolysis of aspirin (ASA) to salicylic 
acid (SA) is a common issue in aspirin crystallization, especially at high temperature 
(Bakar and Niazi, 1983), making crystallization of ASA in water an ideal case study. 
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Figure 9.4. Temperature and concentrations of aspirin (ASA) and degradation byproduct 
salicylic acid (SA), during crystallization of aspirin in water. 
 
As shown in Figure 9.4, a 55 oC saturated ASA solution was prepared and crystallized 
by cooling from 60 oC to 15 oC. Both ASA and SA concentration were monitored 




even though a hot solution was sampled and tested. Figure 9.4 indicates that SA 
concentration starts to increase at 0.6 hours due to hydrolysis of ASA, but it begins to 
decrease at 2.3 hours because of its absorption into ASA crystals (Borsos et al., 2016).  
 
9.3.2 Online UPLC-Based Quick Calibration for UV/vis and Raman Spectroscopy 
Although spectroscopy-based concentration measurements have some disadvantages, 
as described in the introduction, spectroscopic techniques such as UV/vis, IR and Raman 
can provide much faster measurements (i.e. a few seconds) than are possible with online 
UPLC. Therefore there are still many situations in which spectroscopy cannot be replaced 
by online UPLC, for example when fast closed-loop process control is required. However, 
as described in the introduction, one major disadvantage of spectroscopy-based 
concentration measurement is its relatively complicated and time-consuming standard 
calibration procedure, which requires spectroscopy measurements at different 
concentrations, temperatures, etc (Saleemi et al., 2012b). Due to the difficulty of measuring 
concentration in a slurry, clear solutions are widely used in the standard calibration 
approach because their concentrations can be simply calculated from mass balance 
(Saleemi et al., 2012b). As a result, only a limited metastable zone can be covered in this 
type of standard calibration approach because concentration will become unknown once 
the solute starts to crystallize at high supersaturation. Because of the ability of online UPLC 
to measure solute concentration in slurries, this section introduces an online UPLC-based 
quick calibration approach for UV/vis and Raman spectroscopy that overcomes these 
limitations. Simultaneous online UPLC and ATR-UV/vis (or Raman) measurements were 




metastable zone, and then ATR-UV/vis or Raman signals were fitted with online UPLC 
measured concentration, and finally the model was validated in another validation run by 
comparing the calibration calculated and UPLC measured concentrations. In this quick 
calibration approach, the model was trained and used in similar conditions (e.g. slurry 
density, supersaturation range), so it is expected to be robust. 
The first case study employed aspirin in ethanol as a model system. The aspirin UV/vis 
first derivative spectrum and Raman raw spectrum are presented in Figure 9.5. The peak 
heights at 267 nm (UV/vis) and 873 cm-1 (Raman) of the two spectra were used to create 
univariate calibration models. The peak locations were selected by trial and error to 
minimize the influences from particles.  
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Figure 9.5. (a) UV/vis first derivative spectrum, and (b) Raman spectrum of a 25 oC 
saturated aspirin-ethanol solution. 
 
The calibration data are plotted in Figure 9.6. In the first 15 hours, an unseeded fast 
cooling crystallization was carried out followed by a slow heating experiment. This part of 




heating during model training is to make the calibration trajectory cover a large metastable 
zone in order to avoid extrapolation when using the calibration model in crystallization 
experiments. The following equation was used to fit the UV/vis or Raman calibration 
model: 
 Concentration [mg/g] = aT bp c    (9.1) 
where T  is temperature [oC], p  is peak height at 267 nm in UV/vis first derivative 
spectrum or 873 cm-1 in Raman spectrum of aspirin, ,  ,  a b c  are fitted coefficients. The 
UV/vis first derivative spectrum was used to minimize the baseline offsets. From 15 hours 
to 28 hours, further cooling and heating experiments were implemented using different 
seed loadings, cooling and heating rates to validate the calibration model. The coefficients 
were fitted using a least square regression method in software MiniTab 17. The fitted 
coefficients, root mean square error (RMSE) as well as maximum and average errors of 
fitted data in the validation run are summarized in Table 9.3. Although liquid 
chromatography itself is an accurate tool, the online sampling of UPLC may still introduce 
errors. For example, every sampling would take about one and half minutes, therefore it is 
not accurate if concentration changes very quickly within the sampling window, such as 
when nucleation occurs. The errors shown in Table 9.3 are at the similar level as the 
standard approach reported in literature (Saleemi et al., 2012b). But the proposed online 
UPLC-based quick calibration approach is much simpler and more time efficient (1 day 
vs. 1 week) than the standard approach used in literature. 
In Figure 9.6 one may notice that at around 2 hours, right after primary nucleation, there 
was a sharp UV/vis concentration dip that significantly underestimates the aspirin 




absorption and scattering of fine particles or small nuclei (Van Eerdenbrugh et al., 2011). 
The measurement returned to normal values after a while when the nuclei grew larger. The 
UPLC measurements are unaffected by these interferences, providing additional evidence 
that online UPLC is a more robust PAT tool than spectroscopy in these slurry systems. 
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Figure 9.6. UPLC-based UV/vis and Raman quick calibration for aspirin. 
 
Table 9.3. Fitted coefficients and errors of UV/vis and Raman quick calibration model for 
aspirin. 
 UV/vis Raman 
a [-] 0.6108 1.388 
b [-] 1.332e5 4.071e-2 
c [-] 31.18 13.98 
RMSE [mg/g] 6.26 5.97 
Maximum error 5.38% 6.65% 




9.3.3 Online UPLC for Real-Time Product Purity Monitoring 
Based on the online UPLC measurement in the mother liquor, theoretically one can 
calculate the purity of product in real-time using the following mass balance equation: 
 0
0 0
( ) ( )







c API c API
Purity t




  (9.2) 
where 0 ( )c API  and ( )tc API  are API concentration at time 0 and t , 0 ( )c imp  and ( )tc imp  
are impurity concentration at time 0 and t . Two case studies were carried out using aspirin 
(ASA) as API to verify the proposed approach. 
In the first case study, salicylic acid (SA), which is the degradation product and common 
impurity for aspirin, was used as impurity. About 5% SA was spiked into aspirin raw 
materials on purpose. Ethanol was the crystallization solvent. As presented in Figure 9.7, 
a seeded cooling crystallization was implemented. Predicted ASA concentration was 
calculated from the UV/vis and Raman spectra based on the calibration models developed 
in the previous section. The measured ASA and SA concentrations were obtained from 
online UPLC. The predicted ASA product purity was calculated based on equation (9.2). 
The measured ASA product purity was obtained by manually taking slurry samples, 
filtering, washing, dissolving and measuring offline in UPLC. It can be noticed that the SA 
concentration in mother liquor did not change much from initial value during the cooling 
process, indicating the ASA crystallization product purity should be near 100% throughout 
the crystallization according to equation (9.2). The final offline ASA crystallization 
product purity measurement agreed with this prediction. In addition, there was about a 10% 
offset between the predicted ASA concentration from UV/vis or Raman and the measured 




are no longer accurate when the impurity is present due to the overlapped spectra. These 
data further illustrate how online UPLC is especially useful for multi-component systems 
because it can provide accurate concentration measurement for each component 
simultaneously. 
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Figure 9.7. Real-time aspirin (ASA) product purity monitoring with salicylic acid (SA) 
present as impurity. 
 
The second case study used PCM as the impurity because its structure is also similar to 
aspirin. Approximately 100% PCM was spiked into ASA and the two components were 
crystallized together at the same time. As shown in Figure 9.8, at about 1.4 hours ASA 
concentration started to drop when ASA seed crystals were introduced. When ASA 
finished crystallization at about 2.5 hours, PCM started to crystallize and its concentration 




equation (9.2) along with the online UPLC measurement of the mother liquor. Again, the 
predicted purity agreed well with the measured product purity obtained from manual 
sampling and offline analysis of the solid product. Therefore the proposed online UPLC-
based real-time product purity monitoring approach was successfully verified. 
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Figure 9.8. Real-time aspirin (ASA) product purity monitoring with paracetamol (PCM) 
present as impurity. 
 
9.4 Conclusions 
In this work the PATROL UPLC® system with automated process sampling and dilution 
was implemented for online monitoring of pharmaceutical crystallizations. Three online 
UPLC-based applications were proposed and implemented: (1) solute concentration 
monitoring during crystallizations and associated degradation analyses, (2) quick 




time crystallization product purity monitoring. The results show that online UPLC is a 
powerful online PAT tool that can replace or improve the commonly used spectroscopy 
approaches, especially for crystallization processes in impure media. The advantages of 
online UPLC include simple calibration, and accuracy and robustness in the presence of 
impurities, fouling or fine particles. UPLC was also verified as an online PAT tool to 
monitor product purity in real-time for pharmaceutical crystallization. 
In addition to the applications demonstrated here, online UPLC may also be used as a 
tool to control crystallization process in closed-loop. For example, one may have the online 
UPLC communicate the measured solute concentration to crystallization control software 
(e.g. CryMOCO or CryPRINS) so that the crystallization temperature can be adjusted 
dynamically to achieve supersaturation control (SSC) of the crystallization, similar to the 
SSC approach reported in literature using ATR-UV/vis (Saleemi et al., 2012b). The 
advantage of online UPLC-based SSC is that it can work well even if impurities are present, 
whereas ATR-UV/vis-based SSC will likely have errors in the concentration measurements 




CHAPTER 10. CONCLUSIONS AND FUTURE WORK 
10.1 Conclusions 
The design and control of integrated crystallization operation and systems are important 
to meet the needs of improved CQAs, simplified process design and automated process 
control in the manufacturing of APIs. In this dissertation, three integrated crystallization 
operation and systems are investigated, including CCAC systems, integrated crystallization 
and wet milling operation, and crystallization systems in the presence of impurities. 
CCAC systems implemented in both batch and continuous processes can be designed 
and controlled using PBM. In batch processes, it was found that based on the sensitivity of 
the solubility surface, the linear cooling and antisolvent addition profiles should either 
belong to cooling first or antisolvent first strategy to maximize crystal size and minimize 
batch time, depending on whether the initial solution locates at temperature sensitive region 
or antisolvent concentration sensitive region. The proposed PBM based design approach 
can be used to produce operating surfaces based on which the performance of CCAC 
systems can be understood and operating strategies rapidly designed depending on the 
initial concentration, solvent composition and desired yield. In continuous MSMPR 
processes, the optimal operating trajectory to maximize crystal size was proved to be 
similar as in batch processes and the knowledge was found transferrable using PBM based 




in continuous MSMPRC can also be reduced significantly by implementing dynamic 
temperature or/and antisolvent addition profiles. In addition, simple decentralized PID 
control framework was demonstrated infeasible for such integrated CCAC-MSMPR 
systems, whereas NMPC framework was promising to control crystal size and yield 
simultaneously under disturbances or when set-point change was required.  
Wet milling is an unit operation that can induce nucleation and break crystals, therefore 
improved control of CSD can be achieved by integrating it with crystallization. Integrated 
upstream and downstream applications of wet milling in continuous MSMPR cooling 
crystallization was investigated experimentally in this dissertation. The upstream wet mill 
can be used as a continuous in situ seed generator, and the downstream wet mill can 
efficiently reduce crystal size. Improved process yield and reduced width of CSD was also 
observed in such integrated operation. In addition, a FBRM-based closed-loop control 
approach, ADNC, was developed for continuous MSMPR cooling processes to achieve 
automated control of particle number and average crystal size under requirement of set-
point change and disturbance rejection. This ADNC approach was then combined with wet 
milling technique, and a WMADNC approach was developed and implemented 
experimentally to achieve closed-loop controlled primary or secondary nucleation kinetics, 
by using it upstream or downstream. This combined WMADNC approach introduces the 
advantages of both WM and ADNC to continuous crystallization and superior control on 
CSD was observed. 
The characterization of crystallization systems in the presence of impurities is tough due 
to the limitation of PAT currently exists. In this dissertation, a PATROL UPLC® system 




pharmaceutical crystallizations in impure media. This novel online PAT provides an 
efficient and automated approach to monitor concentrations of all components in the 
mother liquor in real-time. It can be used to replace the commonly used inline spectroscopy 
techniques (e.g. UV/vis, IR, Raman) which typically only work for single component 
systems, or to simplify the calibration procedures of inline spectroscopy techniques. A real-
time crystallization product purity monitoring approach was also developed based on 
online UPLC and validated experimentally. 
The modeling and experimental works of this dissertation indicate how PBM and PAT 
can be used to design and control integrated crystallization operation and systems, 
including CCAC systems, integrated crystallization and wet milling operation, and 
crystallization systems in the presence of impurities.  
 
10.2 Future Work 
Some recommendations for future work are as follows: 
1) One limitation of the current model-based control approaches studied is the neglect 
of the uncertainties of models and crystallization kinetics. These uncertainties should be 
considered in the future works to achieve more robust design and control. 
2) The NMPC control framework proposed in Chapter 5 can be implemented in the 
laboratory scale MSMPRC using FBRM, ATR-UV/vis, and software such as OptCon. The 
implementation of NMPC in continuous crystallization will be a milestone for the 
development of advanced control of continuous crystallization processes. 
3) The integrated upstream and downstream applications of wet milling in continuous 




in situ or to reduce crystal size. The influences of wet milling on PFC startup duration, 
yield, average crystal size and width of size distribution can be investigated and 
recommendations of how to integrate wet milling with PFC can be proposed. 
4) The closed-loop control approaches (i.e. ADNC and WMADNC) developed in 
Chapter 7 and Chapter 8 can be expanded to continuous PFC to achieve closed-loop 
controlled primary or secondary nucleation kinetics, and automated control under 
disturbances or set-point change-over. 
5) The online UPLC technique developed in Chapter 9 can be used to implement 
online UPLC-based SSC approach, which should be more robust than the commonly used 
ATR-UV/vis-based SSC approach in impure media. In this feedback control approach, a 
crystallization control software (e.g. CryMOCO) can be used to analyze the real-time 
concentration measurement from online UPLC and to implement a dynamic cooling profile 
to maintain supersaturation at a desired level in closed-loop. 
6) A systematic study of batch versus continuous crystallizations (i.e. MSMPRC, PFC) 
can be carried out from both technical and economic points of view to achieve some general 
recommendations on the selection of the most efficient and economical crystallization 
process. For example, one can anticipate that MSMPRC and PFC are not good options for 
compounds that have very slow growth kinetics due to the requirement of long residence 
times and large operating volume. Batch crystallization, on the other hand, might be able 
to achieve large crystals even in small operating volume by simply increasing the batch 
time. In addition, it is more cost effective to use continuous crystallization for API that is 
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